Introduction {#Sec1}
============

Heterocyclic composites are an important class of organic compounds possessing broad applications in various fields of science \[[@CR1]--[@CR7]\]. One of the most eminent heterocyclic motifs, thiazolidine, is a five-membered heterocycle system having the formula C~3~H~7~NS containing one nitrogen and one sulfur atom, and which exhibits notable medicinal and pharmaceutical properties. In the thiazolidine nucleus, a large number of substitutions are possible on 2, 4 and 5 positions responsible for enhancing the compound\'s pharmaceutical importance. Thiazolidine and its composites are key components of many natural products and drugs (Fig. [1](#Fig1){ref-type="fig"}), and are also present in many synthetic compounds such as anticancer \[[@CR8]--[@CR11]\], antimicrobial \[[@CR12]--[@CR14]\], antitumor \[[@CR15], [@CR16]\], antidiabetic \[[@CR17]\], antiparasitic \[[@CR18], [@CR19]\], anti-inflammatory \[[@CR20]--[@CR22]\], antitubercular \[[@CR23]\], antifungal \[[@CR24]\], antiviral \[[@CR25], [@CR26]\], anti-HIV \[[@CR27]--[@CR29]\], cytotoxicity \[[@CR30]\], antitrypanosomal \[[@CR31]\], antinociceptive and anti-hypernociceptive compounds \[[@CR32]\]. In addition, the use of thiazolidines as an inhibitor of tyrosyl-DNA phosphodiesterase I \[[@CR33]\] and influenza neuraminidase \[[@CR34]\], pro-drugs for the treatment of cystinosis \[[@CR35]\], radioprotective against γ-irradiation \[[@CR36]\] and as S1P1 receptor agonists \[[@CR37], [@CR38]\] has also been reported. They are also used in peptide and protein modification \[[@CR39]\], protein chemical synthesis \[[@CR40]\], as activators to innate immunity \[[@CR41]\] and also act as immunostimulating agents \[[@CR42]\].Fig. 1Some commercially available thiazolidine-based drugs

These derivatives are also involved in various syntheses as synthetic precursors, potential biomarkers for oxidative stress and formaldehyde exposure \[[@CR43]\], heterogeneous catalysts \[[@CR44], [@CR45]\], free radicals, superoxide anion radical and hydroxyl radical scavengers \[[@CR46]--[@CR48]\], inducible nitric oxide synthase (iNOS) inhibitors \[[@CR49]\], to construct non-fullerene small molecules \[[@CR50]\] and on and on. Green chemistry was formulated in the 1990s and includes 12 principles. The green processes diminish the adverse effects of any chemical reaction by following certain criteria viz. catalyst- and solvent-free synthesis and designing of biodegradable and less toxic products with high efficiency. In this review article, we have compiled researches which step ahead toward green chemistry. In the past few years, divergent synthetic strategies \[[@CR51]\] have been introduced aimed at efficient and green synthesis using inexpensive reactants, nontoxic solvents, reusable catalysts, nanoparticle-catalyzed synthesis and solvent-free synthesis with high yields using different techniques such as microwave irradiation (MWI), sonochemistry, surface chemistry and others (Fig. [2](#Fig2){ref-type="fig"}). Multicomponent reactions (MCRs) (Strecker, Ugi, Bucherer-Bergs, Biginelli) are excellent pathways for the synthesis of heterocycles \[[@CR52]\] as they have all the features for ideal synthesis like simple procedure for generating complex hybrid molecules in fewer steps which possess excellent pharmaceutical activity with high atom economy and eco-friendliness \[[@CR53], [@CR54]\]. The notable features of thiazolidine scaffolds compel us to study the literature and outline the current status of thiazolidine, its derivatives and also their biological significance. Recently, Jain et al. \[[@CR55]\] reviewed the biological activity of thiazolidinone derivatives from 2000 to 2011. In 2013, Jain and coauthors \[[@CR56]\] reviewed the multifarious applications of various thiazolidine-2,4-dione derivatives. Nanjan et al. \[[@CR57]\] reviewed the antidiabetic activity of thiazolidinone. But there is no detailed review of the synthesis and biological activity of thiazolidines to date. So here, we have summarized a literature survey of different strategies developed for the synthesis of thiazolidines and their analogs, highlighting their activity and their use as starting materials in the synthesis of various heterocyclic systems with potent pharmaceutical properties during the period of 2014--2019, hoping to inspire new and even more creative approaches for researchers (Fig. [3](#Fig3){ref-type="fig"}). We have also included a comparative study of various synthetic protocols of thiazolidine derivatives with their advantages (+) and disadvantages (−) (Figs. [4](#Fig4){ref-type="fig"}, [5](#Fig5){ref-type="fig"}, [6](#Fig6){ref-type="fig"}, [7](#Fig7){ref-type="fig"}). In this review, an endeavor has been made to underline the recent issues in thiazolidine synthesis like environmental, health, cost and energy issues. By using truly greener pathways, we can overcome these factors for a promising future of thiazolidine derivatives.Fig. 2Different synthetic pathways for the thiazolidine motifFig. 3Synthesis of secondary amines via three different pathways; (iii) represents the efficiency and diversity of MCRs.Modified from Ref. \[[@CR61]\]Fig. 4Comparative study of various synthetic protocols \[[@CR58]--[@CR69]\]Fig. 5Comparative study of various synthetic protocols \[[@CR77]--[@CR86]\]Fig. 6Comparative study of various synthetic protocols \[[@CR87]--[@CR97]\]Fig. 7Comparative study of various synthetic protocols \[[@CR98]--[@CR102]\]

Synthesis of Thiazolidine Derivatives {#Sec2}
=====================================

Acid-Catalyzed Synthesis {#Sec3}
------------------------

Shelke and his coworkers \[[@CR58]\] described a simple, more proficient, less wasteful, cost-effective, one-pot mechanism for the formation of bioactive 2-((substituted)-2-chloroquinolin-3-yl)-3-((substituted) phenyl) thiazolidin-4-ones (**4**) from 2-chloro quinoline-3-carbaldehyde (**1**), aniline (**2**) and thioglycolic acid (TGA) (**3**) with β-cyclodextrin-SO~3~H catalyst (Scheme [1](#Sch1){ref-type="fig"}). The authors studied this procedure in different conditions like various solvents (isopropanol, methanol, acetic acid, toluene, ethanol and DMF) and varied catalysts (p-TSA, sulfamic acid, hydrochloric acid and sulfanilic acid). In this synthesis, β-cyclodextrin-SO~3~H was the most favorable with water as its heterogeneous biopolymer-based solid acid catalyst and was reusable without any vital changes. A safe and greener reaction pathway, low toxicity, high yield of product and easy isolation method were advantages of this protocol. The reaction mechanism is depicted in Scheme [2](#Sch2){ref-type="fig"}. The mechanism shows that β-cyclodextrin-SO~3~H might first activate the aldehyde by enhancing the electrophilic character of its carbonyl moiety which formed an imine intermediate and β-cyclodextrin-SO~3~H anion, and this anion further increased the nucleophilic character of thioglycolic acid which reacted with the imine intermediate and formed an adduct, which was further activated by β-cyclodextrin-SO~3~H anion, followed by ring closure and final dehydration, resulting in formation of novel products.Scheme 1Synthesis of 1-\[(substituted)-2-chloroquinolin-3-yl\]-3-\[(substituted) phenyl\] thiazolidin-4-one **4**Scheme 2Possible mechanism for the synthesis of thiazolidinone derivative **4**.Modified from Ref. \[[@CR58]\]

Bhattacharyya and coauthors \[[@CR59]\] investigated an ingenious, catalytic, regio- and stereoselective methodology for the preparation of various 2-iminothiazolidines from racemic and non-racemic activated aziridines and substituted isothiocyanates using Lewis acid-catalyzed DROC. A general mechanism for DROC-mediated synthesis explained that initially *N*-arylsulfonylaziridine, activated by the Lewis acid (BF~3~·OEt~2~) with TBAHS, gave an intermediate which was highly reactive and showed S~N~2-type ring-opening reaction with isothiocyanates to furnish a new intermediate with an inverted configuration. This intermediate underwent 5-exo-dig cyclization to afford 2-iminothiazolidine (**7**) derivatives, which have high yields and excellent enantioselectivity (Scheme [4](#Sch4){ref-type="fig"}). In this synthetic strategy, different stereoisomers under different conditions gave enantio- and diastereospecific products. Firstly, enantiopure (*R*)-2-phenyl-*N*-tosylaziridine (***R***)**-5a** reacted with phenyl isothiocyanates **6a**, using scandium(III) triflate as a catalyst in dichloromethane at 0 °C, to form (*S,Z*)-*N*,5-diphenyl-3-tosylthiazolidin-2-imine ((***S***)**-7a**) single regioisomer (52%) with low enantiomeric excess (34%) (Scheme [3](#Sch3){ref-type="fig"}). Various solvents, catalyst and temperatures were applied to obtain the best reaction conditions. When the reaction was catalyzed by BF~3~·OEt~2~ and TBAHS (tetrabutylammonium hydrogen sulfate) at −30 °C, high yields were obtained (97%) with excellent enantiospecificity (98% ee). The authors also studied the effect of different substituents on yield and stereoselectivity. This study continued in substituted (*R*)-2-phenyl-*N*-arylsulfonylaziridines and phenyl isothiocyanate under previous reaction conditions and formed corresponding 2-iminothiazolidines with good enantiomeric excess. When 2-aryl-*N*-tosylaziridines cyclized with phenyl isothiocyanate using BF~3~.OEt~2~ and TBAHS in CH~2~Cl~2~ at 0 °C, regioisomers of 2-iminothiazolidines were produced in high yields (up to 99%). With the same previous reaction conditions, except the amount of catalyst, *trans*-2, 3-disubstituted aziridines gave single diastereomers (de, ee \> 99%) related 2-iminothiazolidines in 90% yield (Scheme [4](#Sch4){ref-type="fig"}).Scheme 3Synthesis of thiazolidine derivatives using domino ring-opening cyclizationScheme 4Possible mechanism for the synthesis of thiazolidine derivatives **7** using Lewis acid-catalyzed domino ring-opening cyclization

Multicomponent reactions are used for synthesis of various thiazolidine derivatives under different environmental conditions, some of which are summarized in Table [1](#Tab1){ref-type="table"}. The comparison in Fig. [3](#Fig3){ref-type="fig"} is illustrated in two points, concerning the addition of more than two components in a single step without considering their sequence \[[@CR61]\]. In past years, researchers reviewed the mechanistic and chemical properties of MCRs, their sustainability and relation with biological activity \[[@CR60], [@CR61]\].Table 1Different multicomponent reactions for the synthesis of thiazolidine derivatives

The anti-glioma activity and cytotoxicity of the thiazolidin-4-ones were evaluated by Da Silva and coworkers \[[@CR62]\]. In this procedure, primary amines, aldehyde and mercaptoacetic acid were reacted via one-pot MCR in the presence of BF~3~ and *p*-toluenesulfonic acid (PTSA) and formed derivatives of thiazolidin-4-one (Scheme [5](#Sch5){ref-type="fig"}). Pyridine containing thiazolidinones gave good antitumor activity through decrease in cell feasibility of glioblastoma multiform cells. Among all synthesized derivatives, **9b**, **9e**, **9g** and **10e** exhibited potent antitumor effect against reference cells.Scheme 5Synthesis of thiazolidinone derivatives **9** and **10** in the presence of PTSA/BF~3~

Recently, Rahim et al. \[[@CR63]\] reported a novel and efficient method for the synthesis of arylhydrazide bearing thiazolidinone and analyzed them for α-amylase and urease inhibitors. In this protocol, hydrazine hydrate and 4-cyanobenzoate were refluxed with substituted aldehydes/acetophenone, resulting in corresponding Schiff base **11**, which further reacted with thioglycolic acid using acetic acid to give the final product thiazolidinone **12** (Scheme [6](#Sch6){ref-type="fig"}). A screening of **11a**--**r** and **12a**--**o** was conducted for α-amylase and urease inhibitory processes, respectively. Among all compounds, six derivatives, **11b**, **11e**, **11f**, **11j**, **11k**, **11r**, and nine derivatives, **12a**, **12b**, **12e**, **12f**, **12g**, **12h**, **12j**, **12k** and **12l**, were highly potent inhibitors as compared to reference drug acrobase (α-amylase inhibitor) and thiourea (urease inhibitory), respectively.Scheme 6Synthesis of substituted thiazolidinone derivatives

Base-Catalyzed Synthesis {#Sec4}
------------------------

Kaboudin and colleagues \[[@CR64]\] investigated a novel, facile, one-pot and high-yielding protocol for thiazolidin-4-one derivatives from one-pot, four-component condensation and cyclization of various benzaldehydes **13** and hydrazine with *α*-haloketones and allyl isothiocyanate (Scheme [7](#Sch7){ref-type="fig"}). In order to determine the optimal reaction conditions, the reaction was carried out using different catalysts like NaOH, pyridine, DBU and Et~3~N at different temperatures, and the best results were achieved in the presence of the Et~3~N catalyst with 7 h of reflux in methanol. The plausible reaction mechanism was decoded as the hydrazine reacting with allyl isothiocyanate and aldehyde to afford an intermediate, which showed nucleophilic substitution with *α*-chloroacetylchloride and underwent intramolecular cyclization, generating novel thiazolidin-4-one **14** (Scheme [8](#Sch8){ref-type="fig"}). Easy accessibility of reactant, operation simplicity, mild reaction conditions, clean reaction profile, high yields and purity of products were the notable advantages of this protocol.Scheme 7Synthesis of thiazolidine derivatives **14**(**a**--**r**) using basic catalystScheme 8Putative mechanism for the synthesis of compound **14**.Modified from Ref. \[[@CR64]\]

An efficient and greener one-pot method for the synthesis of a range of bioactive tetrahydrothiazolo\[3,2-*a*\]quinolin-6-ones was employed using cysteamine hydrochloride, 1,1-bis(methylthio)-2-nitro ethylene, trimethylamine with aromatic aldehyde and dimedone in H~2~O/EtOH and triethylamine by Bayat and coworkers \[[@CR65]\] (Scheme [9](#Sch9){ref-type="fig"}). According to the investigation of the reaction mechanism, cysteamine hydrochloride (**15**) initially reacted with 1,1-bis(methylthio)-2-nitroethene (**16**) in H~2~O/EtOH to furnish 2-(nitromethylene)thiazolidine (**18**). Subsequently, aromatic aldehyde (**19**) on condensation with dimedone (**17**) formed an adduct. Further Michael addition of 2-(nitromethylene)thiazolidine **16** and the adduct resulted in the formation of an intermediate, followed by imine--enamine tautomerization, then nucleophilic addition of an amino moiety to the carbonyl group, and, finally, intramolecular cyclization produced desired products **20**(**a**--**p**) in 75--94% yields (Scheme [10](#Sch10){ref-type="fig"}). The remarkable features of this new protocol were operational simplicity, mild reaction conditions, easily available substrates, easy workup, high yield in short time periods and a highly environmentally benign method.Scheme 9Synthesis of thiazolidine derivatives **20a**--**p** using Et~3~NScheme 10Possible mechanism for the synthesis of thiazolidine derivatives **20**.Modified from Ref. \[[@CR65]\]

Santeusanio et al. \[[@CR66]\] reported a domino reaction, also known as a cascade reaction, consisting of at least two subsequent reactions where segregation of the intermediate is not required and occurs intramolecularly with advantages like less waste generation, fast reaction and high atom economy. In the multifarious thiazolylidene ring congregation, ATAs (β-amidothioamides) can act as hetero-mononucleophiles or heterodinucleophiles. A library of thiazolylidene derivatives **24** and **25** was synthesized by the reaction of ATAs **21** and DDs **22** and **23** (Scheme [11](#Sch11){ref-type="fig"}). As a result, two types of products were formed with different pathways. A variety of solvents such as MeOH, THF and DMF were used for the completion of reaction without using a base, but these conditions did not give satisfactory results. Further study showed that when the reaction was performed with an organic base in CHCl~3~ at ambient temperature, the best results were obtained.Scheme 11Synthesis of thiazolidine derivatives **24** and **25** using different ring closure pathways.Modified from Ref. \[[@CR66]\]

A simple, more efficient, cost-effective and convenient synthetic procedure for the synthesis of 2-heteroaryliino-1,3-thiazolidin-4-ones using 3-aminothiophenes, chloroacetyl chloride and ammonium thiocyanate along with different solvents and catalysts was reported by Revelant et al. \[[@CR67]\] (Scheme [12](#Sch12){ref-type="fig"}). Compounds **26** and **27** were found effective in antiproliferative activity against five cancer cell lines, i.e. MDA-MB-231, HCT116, HT29, MCF7 and SW620.Scheme 12Synthesis of compounds **26** and **27** under basic conditions

Yahiaoui and coauthors \[[@CR68]\] described a reliable and simple protocol for the preparation of 2-thioxo-thiazolidin-4-ones **28** by condensation of aromatic amines and CS~2~ using NH~4~OH and chloroacetic acid, and the compounds were further treated with CH~3~CN under basic conditions (Scheme [13](#Sch13){ref-type="fig"}). The authors also developed a combined experimental and theoretical approach on the molecular structure of 2-thioxo-3*N*-(2-methoxyphenyl)-5 \[4′-methyl-3′*N*-(2′-methoxyphenyl) thiazol-2′(3′H)-ylidene\] thiazolidin-4-one.Scheme 13Synthesis of 2-thioxo-3*N*-(2-methoxyphenyl)-5\[4′-methyl-3′N-(2′-methoxyphenyl) thiazol-2′(3′H)-ylidene\] thiazolidin-4-one

Hassan and colleagues \[[@CR69]\] synthesized new thiazolidine derivatives **30**(**a**--**d**) from hydrazide **29**, ethyl bromoacetate and anhydrous sodium acetate using ethanol, and also evaluated their anticancer activity against HepG2, PC-3, MCF-7 and A549 human cancer cell lines (Scheme [14](#Sch14){ref-type="fig"}). However, these compounds did not show good anticancer activity.Scheme 14Synthesis of substituted thiazolidine derivatives under basic conditions

Nanoparticle-Catalyzed Synthesis {#Sec5}
--------------------------------

Nanoparticles have a large surface-to-volume ratio and active coordination parts, compared to bulk materials. Nano-heterogeneous catalyst shows high activity, low energy consumption and 100% selectivity; therefore, these are suitable for the preparation of bioactive heterocyclic compounds \[[@CR70], [@CR71]\]. Recently, magnetic nanoparticles have received great attention because of their enormous benefits such as cost-efficiency, good stability, easy separation and high surface area \[[@CR72]\]. Coating of nanoparticles with various materials like copper \[[@CR73]\], chitosan \[[@CR74]\] and [l]{.smallcaps}-proline \[[@CR75]\] improves their activity \[[@CR76]\].

Safaei-Ghomi and his group \[[@CR77]\] developed a novel, efficient, pseudo-five-component preparation of bis-thiazolidinones **31**(**a**--**j**) from substituted benzaldehyde, ethylenediamine and TGA (**3**) with nano-CdZr~4~(PO~4~)~6~ as a retrievable and robust catalyst (Scheme [15](#Sch15){ref-type="fig"}). The 0.6 mol% catalyst loading was sufficient for the good yield of products. It was observed that the best results were obtained with aromatic aldehydes with electron-withdrawing groups (EWG) as compared to electron-donating groups (EDG). The catalyst CdZr~4~(PO~4~)~6~ provided the surface to carry out the reaction. Primarily imine formed as an intermediate by the reaction of benzaldehyde and ethylene diamine on the surface of the catalyst, which activated the C=O, C=N and S--H groups. Then, attack by the sulfur atom on the activated imine group occurred, followed by intramolecular cyclization to give thiazolidinones (Scheme [16](#Sch16){ref-type="fig"}).Scheme 15Synthesis of bis-thiazolidinones using nano-CdZr~4~(PO~4~)~6~Scheme 16Mechanism for the synthesis of bis-thiazolidinones using nano-CdZr~4~(PO~4~)~6~.Modified from Ref. \[[@CR77]\]

Nano-CoFe~2~O~4~\@SiO~2~/PrNH~2~, an appropriate addition in the field of synthetic chemistry, was achieved by Safaei-Ghomi and coworkers \[[@CR78]\]. The treatment of CoFe~2~O~4~\@SiO~2~ with APTES in refluxing toluene led to the concept of CoFe~2~O~4~\@SiO~2~/PrNH~2~ nanoparticles as a peculiar magnetically recyclable, green and efficient catalyst, and the compound was found to be effective in the synthesis of 1,3-thiazolidin-4-ones **32** via MCRs of aniline, chloro benzaldehyde and TGA with different solvents (Scheme [17](#Sch17){ref-type="fig"}). The catalyst was reusable for seven progressive cycles. This novel reaction was carried out on different aromatic aldehydes and aniline, and it was concluded that the EWG in aldehydes reacted faster as compared to EDGs. Two mechanisms have been proposed for the reaction. In the first mechanism, aldehyde and amine interacted to form imine intermediate, then a sulfur atom of mercaptoacetic acid attacked the carbon atom of imine which was catalyzed by CoFe~2~O~4~\@SiO~2~/PrNH~2~ NPs followed by intramolecular cyclization to give thiazolidinones (Pathway A). In the second mechanism, initially, formation of amide took place from aldehyde, thioglycolic acid and amine followed by cyclocondensation of a carbonyl group of aldehyde with sulfur and a nitrogen motif catalyzed by the same NPs to give cyclic compounds, thiazolidinones (Pathway B) (Scheme [18](#Sch18){ref-type="fig"}).Scheme 17Synthesis of 1,3-thiazolidin-4-ones using nano-CoFe~2~O~4~\@SiO~2~/PrNH~2~Scheme 18Mechanism for the synthesis of 1,3-thiazolidin-4-ones using nano-CoFe~2~O~4~\@SiO~2~/PrNH~2~.Modified from Ref. \[[@CR78]\]

The convenient and green FeNi~3~-ionic liquid (IL) magnetic nanoparticle (MNP)-promoted solvent-free, one-pot synthesis of varied 1,3-thiazolidin-4-ones from amine, aldehyde and TGA in excellent yields was established by Sadeghzadeh et al. \[[@CR79]\] (Scheme [19](#Sch19){ref-type="fig"}). The use of robust, stable, easily recoverable, inexpensively synthesized and reusable magnetic ILs supported on FeNi~3~ nano-catalyst made the reaction protocol eco-friendly and of high synthetic utility. This protocol has significant additional advantages such as being solvent-free, an immobilization technique and a fast reaction procedure. The authors applied various conditions like different solvents and catalyst to obtain the sustainable reaction conditions, and it was observed that 0.001 g of FeNi~3~-IL MNPs at 50 °C without solvent was suitable for the reaction. The predicated mechanism for this synthesis was explained as the condensation of aldehyde and amine to form an imine intermediate which combined with thioglycolic acid to furnish the intermediate that consequently cyclized to afford product **33** (Scheme [20](#Sch20){ref-type="fig"}).Scheme 19Synthesis of 1,3-thiazolidin-4-one using FeNi~3~-IL MNPsScheme 20Mechanism for the synthesis of 1,3-thiazolidin-4-one using FeNi~3~-IL MNPs.Modified from Ref. \[[@CR79]\]

An adept, feasible, one-pot synthesis of 1,3-thiazolidin-4-one derivatives was introduced by Azgomi et al. \[[@CR80]\] using MNPs\@SiO~2~-IL (nano-Fe~3~O~4~\@SiO~2~-supported ionic liquid). The reaction was derived from the condensation of arylaldehyde, thioglycolic acid and anilines in solvent-free conditions with high to excellent yields (Scheme [21](#Sch21){ref-type="fig"}). The pathway of reaction involved MNPs\@SiO~2~-IL, which activated oxygen of the carbonyl group and amine for the formation of an imine intermediate via enhancing the electrophilicity of the carbonyl group. The thioglycolic acid attacked the activated imine intermediate and formed a new intermediate, which, upon activation by catalyst MNPs\@SiO~2~-IL, produced **34**(**a**--**j**) (Scheme [22](#Sch22){ref-type="fig"}). The authors studied the effect of various catalysts such as dicarbethoxydihydrocollidine (DDC), Baker's yeast, SiO~2~, HClO~4~-SiO~2~, H~2~SO~4~-SiO~2~, TfOH-SiO~2~ (trifluoromethenesulfonic acid-SiO~2~), Bi(SCH~2~COOH)~3~ and MNPs\@SiO~2~-IL in different solvents like EtOH, H~2~O, CH~2~Cl~2~, EtOAc, DMF, CH~3~CN, THF and toluene and also under solvent-free conditions. The use of 0.0007 g of MNPs\@SiO~2~-IL at 70 °C without solvent exhibited the best results. The catalyst was reused for ten runs without considerable loss in its activity.Scheme 21Synthesis of 1,3-thiazolidin-4-one **34** using MNP\@SiO~2~-ILScheme 22Mechanism for the synthesis of 1,3-thiazolidin-4-one **34** using MNP\@SiO~2~-IL.Modified from Ref. \[[@CR80]\]

Ionic Liquid-Assisted Synthesis {#Sec6}
-------------------------------

Ionic liquids are powerful solvents and catalysts, which have various advantages as they are nonvolatile, have low vapor pressure, minimize chemical waste, have a wide range of anion and cation combinations, have high chemical and thermal stability and are easily recyclable.

Subhedar et al. \[[@CR81]\] observed one-pot, multicomponent reaction (MCR) using \[Et~3~NH\]\[HSO~4~\] as a catalyst, and the products were found in excellent yields with a high purity, whereas lower yields were obtained in the absence of the catalyst. An environmentally and highly efficient protocol for 1,3-thiazolidin-4-ones was prepared from cyclocondensation of aniline, aromatic aldehyde and thioglycolic acid with \[Et~3~NH\]\[HSO~4~\] (Scheme [23](#Sch23){ref-type="fig"}). The catalyst was reused five times, and high yields (80%) were obtained at 80 °C when 25 mol% of the catalyst was used. 1,3-Thiazolidin-4-ones were tested in vitro for their antimycobacterial activity, antimicrobial activity and cytotoxicity. This analysis showed that these derivatives displayed excellent selectivity towards dormant *M. Bovis BCG* and *MTB H37Ra* strains.Scheme 23Synthesis of 1,3-thiazolidin-4-ones using \[Et~3~NH\]\[HSO~4~\]

Chen et al. \[[@CR82]\] reported a one-pot, three-component condensation reaction of substituted 2-aminobenzimidazoles, isothiocyanate and triethylamine using ethylene dichloride (EDC) as a solvent and formed 2-imino-1,3-thiazolidines and 2-imino-1,3-thiazolines (Scheme [24](#Sch24){ref-type="fig"}). In this protocol, 2-aminobenzimidazole adhered on ionic liquid (IL), then isothiocyanate proceeded with IL-anchored 2-aminobenzimidazole, yielding isothiourea which combined with 1,2-dichloroethene by inter- and intramolecular processes and generated 2-imino-1,3-thiazolidines. ILs provided high atom economy and simplicity in product isolation (Scheme [25](#Sch25){ref-type="fig"}).Scheme 24Synthesis of thiazolidine derivatives using ionic liquidsScheme 25Mechanism for the synthesis of thiazolidines **36** using ionic liquids.Modified from Ref. \[[@CR82]\]

Malla and colleagues \[[@CR83]\] investigated an ingenious, greener, solvent-free, high-yielding, one-pot, three-component synthesis of thiazolidine derivatives from 1,3-diketones, cyanates and ethylchloroacetate using \[Et~3~NH\]\[HSO~4~\] IL as a catalyst, which afforded good yields (92--98%) with high purity (Scheme [26](#Sch26){ref-type="fig"}). Here, \[Et~3~NH\]\[HSO~4~\] is an inexpensive, eco-friendly catalyst, stable in water and air, exhibited both catalytic and medium engineering capability, is recyclable up to five runs without any significant loss of catalytic activity and also eliminated the additional use of the solvent. According to the possible reaction mechanism, initially, ionic liquid protonated the cyanates to furnish an intermediate, which underwent nucleophilic addition with 1,3-diketones and formed a new intermediate, which further reacted with ethylchloroacetate with consequent expulsion of HCl. The nitrogen of the compound attacked the carbonyl group and eliminated ethanol to form a C--N bond and finally formed the products **37** (Scheme [27](#Sch27){ref-type="fig"}). The authors applied diverse catalysts like \[Et~3~NH\]\[HSO~4~\], \[Me~3~NH\]\[HSO~4~\], \[Et~2~NH~2~\]\[H~2~PO~4~\] and \[Me~3~NH\]\[CH~3~COO\], and various solvents such as dimethyl sulfoxide (DMSO), EtOH, DMF, CH~3~NO~2~, toluene and \[Et~3~NH\]\[HSO~4~\] in different amounts at varied temperature for optimization of the reaction conditions w.r.t. good yields and time (Table [2](#Tab2){ref-type="table"}). The solvent also played a crucial role in the yields of reaction; i.e. nonpolar solvent (85%) ˃ polar-aprotic solvent (55--74%) ˃ polar-protic solvent (52%). However, the best results were obtained at 120 °C in 20 mol% of IL as a reaction media under solvent-free conditions. High atom economy, operational simplicity, an environmentally friendly nature, easy catalyst synthesis, low waste material, mild conditions and shorter reaction time are the notable advantages of this procedure.Scheme 26Synthesis of thiazolidine derivatives **37** using \[Et~3~NH\]\[HSO~4~\]Scheme 27Possible mechanism for the synthesis of thiazolidinones **37**.Modified from Ref. \[[@CR83]\]Table 2Synthesis of thiazolidinone derivatives using different substituents (**37a**--**37n**)

Novel thiazolidinone derivatives **38** were synthesized by Sadeghzadeh and coauthors, \[[@CR84]\] in which aldehyde, amine and thioglycolic acid were reacted using heterogeneous catalyst Fe~3~O~4~/SiO~2~/Salen/Mn/IL MNPs under solvent-free conditions at ambient temperature with good to excellent results (Scheme [28](#Sch28){ref-type="fig"}). Here, the catalyst offered several advantages viz. ease of synthesis, easy recovery by an external magnet, operational simplicity and reusability up to six runs without any significant loss of activity. The authors applied various catalysts such as SiO~2~/Salen/Fe~3~O~4~/Mn/IL MNPs, phosphotungstic acid, NbCl~5~ \[niobium(v)chloride\], PEG--SO~3~H (sulfonated polyethylene glycol), InCl~3~ (indium chloride), Pd(PPh~3~)~4~, cerium(IV) ammonium nitrate and nano-SiO~2~/TiO~2~/RuO~2~/Pd/FeNi~3~ in different solvents (H~2~O, EtOH, THF, CH~2~Cl~2~, *n*-hexane) at different temperatures for optimization of the reaction condition w.r.t. yields and time. By the study, they concluded that Fe~3~O~4~/SiO~2~/Salen/Mn/IL MNP without solvent at room temperature gave the best results. This method has many merits, including high atom economy, synthetic efficiency, solvent-free conditions and shorter reaction time.Scheme 28Synthesis of 1,3-thiazolidin-4-one **38** using Fe~3~O~4~/Salen/Mn/IL MNPs

Eutectic Solvent-Assisted Synthesis {#Sec7}
-----------------------------------

Yedage and his group \[[@CR85]\] synthesized 1,3-thiazolidin-4-ones by MCRs with aniline, benzaldehyde and TGA (**3**) in the presence of choline chloride:glycerol (1:2) as DESs (Scheme [29](#Sch29){ref-type="fig"}). DESs are the particular type of ionic solvents formed by combination of a Lewis acid, Brønsted acid and a base. These are used as an eco-friendly and reusable solvents or catalysts due to many characteristics like lower melting point as compared to individual components because of delocalization of charge on the whole mixture, high viscosity and inadequate density, so they can be liquid at the broad range of atmospheric conditions and incombustible. The mechanism of the reaction showed that DES firstly interacted with the oxygen of the carbonyl compound, and, simultaneously, the nitrogen atom of aniline attacked the carbon atom; then, imine was formed as an intermediate, which further reacted with TGA to form the product. At last, DES was removed and reused at least five times continuously without any damage.Scheme 29Synthesis of 1,3-thiazolidin-4-ones using DES

Catalyst- and Solvent-Free Synthesis {#Sec8}
------------------------------------

Dahiya et al. \[[@CR86]\] investigated a series of 2-iminothiazolidines via DROC reaction without use of any catalyst and solvent (Scheme [30](#Sch30){ref-type="fig"}). An ecologically benign process containing inactive aziridine and aroyl isothiocyanates under the solvent-free conditions at room temperature produced 2-iminothiazolidines. Here, aroyl isothiocyanates played a role either as an ambient nucleophile (--SCN or --NCS) or electrophile. When this reaction was accomplished with solvent, the yield was comparatively low. This process was examined with substituted aziridine and aroyl isothiocyanates, and the authors demonstrated that the synthesis was facile when aziridine bearing electron-donating groups and aroyl isothiocyanates having electron-withdrawing substituents were taken. The mechanism of the reaction showed that this methodology involved \[3+2\] cycloaddition reaction which occurred by the S~N~2 pathway. This was confirmed by the reaction of optically active aziridine and aryl isothiocyanate, and it gave optically active product. The lone pair on the nitrogen of aziridine made it a nucleophile, and its attack on the sp hybrid carbon of heterocumulene NCS formed a thiourea intermediate, whose sulfur atom attacked the benzylic site of aziridine, and ring opening occurred (Scheme [31](#Sch31){ref-type="fig"}).Scheme 30Synthesis of 2-iminiothiazolidine via \[3+2\] cycloaddition reactionScheme 31Possible mechanism for the synthesis of 2-imino thiazolidine **40** via \[3+2\] cycloaddition.Modified from Ref. \[[@CR86]\]

Microwave-Assisted Synthesis {#Sec9}
----------------------------

Microwave treatment promotes better thermal management of reactions which are temperature-sensitive, and produces uniform heating and increase product yields using mild conditions. Mahmoodi et al. \[[@CR87]\] reported an appropriate, one-pot, three-component reaction for the preparation of thiazolidinones using KSF\@Ni as a heterogeneous catalyst by the reaction of aldehydes, thiosemicarbazide and maleic anhydride under MWI (Scheme [32](#Sch32){ref-type="fig"}). Microwave MCRs have several advantages such as shorter reaction time, high product yields, cleaner reaction profile, minimal by-products, and greater efficiency and cost-effectiveness. Heterogeneous catalyst has special features such as a long life span, easy removal and recovery, an innoxious nature, and is safe for storage. When the reaction was performed in the polar solvent, e.g. EtOH, DMF and MeOH, the reaction proceeded slowly. This method worked successfully under MWI at 70 °C and 50 psi in the mixture of DMF:toluene (1:1) in short reaction time (5 min) to give high yield (60%). The catalyst was recyclable for seven runs and gave almost the same yield of products. These products showed in vitro antibacterial activity against Gram-positive and Gram-negative bacterial strains *E. coli*, *P. aeruginosa*, *S. aureus* and *M. luteus.*Scheme 32Synthesis of thiazolidinone **41** using MW irradiation

Sangeetha and coworkers \[[@CR88]\] disclosed microwave-assisted, solvent-free synthesis of thiazolidine derivatives (**42**) using Amberlite IR-120H resin as a greener and reusable catalyst. 3/5-Alkyl-2,6-diarylpiperidin-4-ones were condensed with thiosemicarbazide and ethyl-2-bromopropionate under 250 W MWI, which afforded high yield of 2,6-diarylpiperidin-4-ylidene thiazolidin-4-one derivatives within 3--6 min. In contrast, in the conventional method, it took more time and gave comparatively low yields (Scheme [33](#Sch33){ref-type="fig"}). All the synthesized compounds were evaluated for in vitro antibacterial activity against five different bacterial strains *S. aureus*, *S. pyogenes*, *P. aeruginosa*, *K. pneumoniae* and *E. coli* and antitubercular activity against *M. tuberculosis* H37Rv, using streptomycin and isoniazid (INH) as standard drugs, respectively. Among all compounds, most displayed good antibacterial potency, and **42c** and **42d** showed high antitubercular activity.Scheme 33Synthesis of new thiazolidine derivatives under MWI

Ultrasound-Assisted Synthesis {#Sec10}
-----------------------------

Ultrasound irradiation is used as an alternative source of energy, providing a green pathway for various reaction pathways \[[@CR89]\] and is based on the acoustic cavitation phenomenon. Safaei-Ghomi and coauthors \[[@CR90]\] designed a facile, effective, one-pot, three-component synthesis of thiazolidinones from aldehyde, aniline and TGA using nano-CdZr~4~(PO~4~)~6~ as an effective heterogeneous catalyst applying 60 W ultrasonic irradiation (Scheme [34](#Sch34){ref-type="fig"}). In this method, initially carbonyl groups of aldehyde and amine reacted to form an imine intermediate, which was further attacked by the sulfur atom of thioglycolic acid and underwent intramolecular cyclization by removal of water to furnish 1,3-thiazolidin-4-ones with 88% yield in 25 min. According to the reaction mechanism, it was suggested that nano-CdZr~4~(PO~4~)~6~ activated the carbonyl moiety of aldehyde and acid via coordinating with the carbonyl oxygen (Scheme [35](#Sch35){ref-type="fig"}). For comparative study, the authors employed diverse solvents, e.g. H~2~O, EtOH, PhMe, THF and DMF, and catalysts like H~2~SO~4~ and nano-SnO/ZrO~2~/CdZr~4~(PO~4~)~6~. However, PhMe and nano-CdZr~4~(PO~4~)~6~ were proved best as they gave high yields in short reaction time. The authors also studied the reaction under reflux conditions, but it displayed low yields in long reaction time as compared to ultrasonic irradiations. The use of nano-CdZr~4~(PO~4~)~6~ as an efficient, highly active, easily recovered, eco-friendly catalyst with notable reusability without loss of its activity is the superior feature of this method. Simple reaction procedure, easily available reactants, use of sonochemical technique, high yields, synthetic efficiency, easy workup and short reaction time are the additional benefits of this protocol.Scheme 34Synthesis of 1,3-thiazolidin-4-ones by nano-CdZr~4~(PO~4~)~6~Scheme 35Mechanism for the synthesis of thiazolidine derivatives using nano-CdZr~4~(PO~4~)~6~.Modified from Ref. \[[@CR90]\]

Shaabani et al. \[[@CR91]\] reported novel MCRs for synthesis of pseudopeptide-linked rhodanine scaffolds using combination of tandem Michael/domino cycloaddition/Ugi reaction strategy. In this diversity-oriented synthesis, initially, primary amines, carbon disulfide and maleic anhydride were condensed to form thiazolidine **44**, which further reacted with benzaldehydes, aniline and isocyanides using water under ultrasound irradiations to produce final product **45** in good yields (Scheme [36](#Sch36){ref-type="fig"}). While using conventional stirring, the conversion rate was very slow. The use of easily available substrate, green solvent, ultrasound radiations and without use of any catalyst make the reaction protocol inexpensive and eco-friendly. The authors have also investigated the effect of solvents like DMF, THF, EtOH and CH~3~CN on the reaction.Scheme 36Synthesis of pseudopeptides containing rhodanine scaffolds

Catalyst-Free Synthesis {#Sec11}
-----------------------

Salehitabar et al. \[[@CR92]\] demonstrated the feasible methodology for the synthesis of ethyl 5-(alkylimino)-4-hydroxy-2-(arylimino)-3-alkylthiazolidine-4-carboxylates **46** from ethyl 3-chloro-3-(alkylimino)-2-oxopropanoate with 1-alkyl-3-arylthioureasin MeCN (acetonitrile) at room temperature via one-pot synthesis to afford various derivatives in good yields. The authors applied various solvents such as acetone, dry MeCN, tetrahydrofuran or toluene to achieve the best reaction conditions and concluded that dry MeCN was suitable and gave 73% yield at room temperature. Ease of operation, broad range of substrate, high synthetic utilit, and good yields are the main advantages of this procedure (Scheme [37](#Sch37){ref-type="fig"}).Scheme 37Putative mechanism for the synthesis of compound **46**.Modified from Ref. \[[@CR92]\]

Halimehjani et al. \[[@CR93]\] proposed the rapid, one-pot, three-component synthesis of thiazolidine-2-thiones using nitroepoxide, primary amine and carbon disulfide in H~2~O at ambient temperature with good yield of products (Scheme [38](#Sch38){ref-type="fig"}). Simplicity, efficiency, mild conditions, high yield of products and short reaction times are the attracting features of this protocol.Scheme 38Synthesis of thiazolidine-2-thiones without using catalyst

A novel catalyst-free, one-step synthesis of versatile thiazolidine derivative **48** has been developed by Aly and coworkers \[[@CR94]\] using bisthiosemicarbazones and DMAD in methanol to afford good yields (Scheme [39](#Sch39){ref-type="fig"}). All synthesized compounds were screened for antagonist of the leukotriene B4 (LTB4) receptor. Some molecules were found potently active towards BLT1 and BLT2 receptors.Scheme 39Synthesis of thiazolidine derivatives under catalyst-free conditions

Solvent-Free Synthesis {#Sec12}
----------------------

Ebrahimi and coworkers \[[@CR95]\] reported the synthesis of 1,3-thiazolidin-4-one using APS (ammonium persulfate) as a catalyst under solvent-free conditions. The use of an economical catalyst, high yield and high atom economy are the benefits of this reaction. The synthesis involved cyclocondensation reaction of substituted aniline, benzaldehyde and thioglycolic acid (Scheme [40](#Sch40){ref-type="fig"}). The reaction was tested under different conditions viz. solvents, temperature and catalysts. The suitable conditions were solvent-free synthesis at 90 °C in the presence of 10 mol% of APS which yielded 84% product. To explore the synthetic utility of the protocol, different aldehydes were taken, and the yield of products was not sensitive to electronic variations and steric factor.Scheme 40APS-catalyzed synthesis of thiazolidinon-4-ones **49**

Metal-Catalyzed Synthesis {#Sec13}
-------------------------

A novel approach for the construction of \[60\]-fullerothiazolidinethiones from C~60~, aliphatic amines and CS~2~ via Cu-catalyzed aerobic oxidative reaction was developed by Wu et al. \[[@CR96]\] (Scheme [41](#Sch41){ref-type="fig"}). The authors applied various catalysts viz. CuSO~4~·5H~2~O, CuCl~2~, CuBr~2~, CuCl, CuBr, CuI and CuCl~2~·2H~2~O in different solvents like DMF/o-DCB, o-DCB and DMF for good yields and reaction time. From the study, they concluded that the best results were obtained in the presence of Cu(OAc)~2~·H~2~O (20 mol%) with DMF/o-DCB (4:1). The suggested reaction mechanism showed that primary amine and carbon disulfide reacted in DMF and o-DCB in aerobic conditions to produce dithiocarbamic acid and further reacted with C~60~ to form aminium radical cation and C~60~ radical anion via a SET mechanism. Oxidative amination reaction took place in the C~60~ radical anion, O~2~ and aminium radical cation to form a C~60~--N bond, followed by Cu-catalyzed aerobic oxidation to produce the C~60~--S bond (Scheme [42](#Sch42){ref-type="fig"}).Scheme 41Synthesis of \[60\]fullerothiazolidinethiones **50** by DMFScheme 42Mechanism for the synthesis of \[60\]fullerothiazolidinethiones **50**.Modified from Ref. \[[@CR96]\]

Shehzadi et al. \[[@CR97]\] developed an ingenious, high-yielding, one-pot four-component strategy for the synthesis of a library of thiazolidine-2-imines from aldehydes, alkynes, amines and isothiocyanates using Cu(I) and Zn(II) as composed catalyst, and examined their inhibitory activity against acetylcholinesterase (AChE) (Scheme [43](#Sch43){ref-type="fig"}). The authors applied different catalysts, solvents and temperature range using various ratios of reactants to optimize reaction parameters. According to the possible reaction mechanism, initially, metal acetylide attacked imine and generated an alkyn-amide nucleophile, which further reacted with isothiocyanate as an electrophile to form an intermediate. This intermediate has two nucleophilic atoms, thus two possibilities occur: nitrogen attack gave S-cyclized product thiazolidine-2-imine; and sulfur attack produced N-cyclized product imidazolidine-2-thione **51**. Single-crystal X-ray analysis confirmed the existence of 2-imino thiazolidine. All analogs demonstrated good inhibition activity, but derivative **51 s** exhibited 88-fold stronger inhibition (IC50, 0.0023 ± 0.0002 μM) than neostigmine methyl sulfate (standard drug).Scheme 43Synthesis of thiazolidin-2-imines **51** using metal catalyst

Multistep Synthesis {#Sec14}
-------------------

A series of novel 4-thiazolidinone containing 1,8-dioxo-octahydroxanthene derivatives were prepared by Robati and colleagues \[[@CR98]\] by the reaction of 1,3-dicarbonyl cyclic compounds, nitro benzaldehyde and isothiocyanate with dialkylacetylene dicarboxylates in ethanol at ambient temperature via four-component reaction. The reaction was accompanied by an economical catalyst and less harmful solvent under mild reaction conditions, with larger product yields and fewer waste products. This procedure consisted of sequential addition of 1,3-cyclohexanedione and nitro benzaldehydes to form nitro 1,8-dioxo-octahydroxanthene derivatives, which underwent reduction by SnCl~2~·2H~2~O to produce the amino octahydroxanthene, that, upon refluxing with isothiocyanates, formed thioureas, which were then subjected to further reaction with dialkylacetylene dicarboxylate (DAAD) to form the final products **52** (Scheme [44](#Sch44){ref-type="fig"}).Scheme 44Synthesis of 1,8-dioxo-octahydroxanthene derivatives containing 4-thiazolidinone **52**(**a**--**f**)

A nitrogen equivalent of an aldehyde or ketone where the carbonyl group is exchanged by an imine or azomethine group is termed as a Schiff base. This is the most consequential moiety in the medicinal and pharmaceutical fields. Kandile et al. \[[@CR99]\] developed a novel synthesis by reacting a Schiff base and TGA with anhydrous ZnCl~2~ or DMF, and the product, bis spiro\[(5-methylindoline3,2-(4 H) thiazolidine)-2,40(1H)-dione\]1,10-biphenyl, was obtained (Scheme [45](#Sch45){ref-type="fig"}) and further scrutinized for antimicrobial activity.Scheme 45Synthesis of bis spiro\[(5-methylindoline3,2-(4H)thiazolidine)-2,40(1H)-dione\]1,10-biphenyl derivatives **53**

The novel synthesis of 4-thiazolidinones was reported by Cihan-Üstündag et al. \[[@CR100]\]. The protocol followed multistep synthesis as initially p-fluoro aniline reacted with NaNO~2~ and converted into the respective diazonium salt, which combined with ethyl-2-benzyl-3-oxobutanoate, which was further refluxed in concentrated HCl to produce ethyl 5-fluoro-3-phenyl-1*H*-indole-2-carboxylate. Ethyl 5-fluoro-3-phenyl-1*H*-indole-2-carboxylate was converted to respective hydrazide in the presence of hydrazine and was attacked by isothiocyanates to form substituted thiosemicarbazides, further cyclized using ethyl bromoacetate and fused sodium acetate to give desired products, 5-fluoro-*N*′-(4-oxo-3-substituted-1,3-thiazolidinon-2-ylidene)-3-phenyl-1*H*-indol-2-carbohydrazides **54**(**a**--**g**) (Scheme [46](#Sch46){ref-type="fig"}).Scheme 46Synthesis of thiazolidine derivatives **54**(**a**--**g**) via multistep synthesis

On-Surface Synthesis {#Sec15}
--------------------

The convenient, rapid, highly reproducible, one-pot, three-component synthesis of 4-thiazolidinone derivatives by the condensation of aldehyde, amine and TGA (**3**) at room temperature with silica gel as promoter was established by Thakare and coworkers \[[@CR101]\] (Schemes [47](#Sch47){ref-type="fig"}, [48](#Sch48){ref-type="fig"}). The possible reaction pathway of the reaction indicated that aldehyde along with amine produced an imine intermediate which combined with thioglycolic acid to form another intermediate. Silica gel activated the carbonyl group by increasing their electrophilicity, and, consequently, intramolecular addition took place, and a new intermediate was obtained. On further removal of H~2~O molecule, the cyclized product of substituted 4-thiazolidinone was obtained. The authors investigated this reaction in various solvents like THF, Et~2~O, acetonitrile, dichloromethane and 1,2-dichloroethene, but dichloromethane was found to be the most suitable. The products were obtained without any workup procedure. Immediate synthesis and use of inexpensive and nontoxic chemicals make this protocol green and eco-friendly.Scheme 47On-surface synthesis of thiazolidinone derivatives **55**(**a**--**w**)Scheme 48Silica gel-mediated synthesis of thiazolidininone **55**.Modified from Ref. \[[@CR101]\]

A simple and efficient silica gel-mediated synthesis of thiazolidine derivatives was developed by Singh and colleagues \[[@CR102]\]. The derivatives were also examined as antiproliferative agents. In this method, propargyl amine and isothiocyanate reacted in CH~2~Cl~2~ that underwent slow autoxidation at room temperature using CDCl~3~ to afford thiazolidin-4-ones **56** in good to high yields (Scheme [49](#Sch49){ref-type="fig"}). The antiproliferative properties were investigated against HCT-116 (colon) and MCF7 (breast) cancer cell lines using MTT growth assay. Some of the synthesized analogs showed good activity without affecting normal cell lines.Scheme 49Synthesis of (*Z*)-2-imino-5-(*Z*)ylidene-*N*-substituted thiazolidines **56**

Biological Activity of Thiazolidine Derivatives {#Sec16}
===============================================

Antimicrobial Activity {#Sec17}
----------------------

Abdel Hafez and coworkers \[[@CR103]\] developed a series of 2-(2-(1-(3,4-dimethoxyphenyl)ethylidine)hydrazono)-substituted thiazolidinone derivatives and tested them for antimicrobial activity against fungal strains (*A. niger* and *A. flavus*) and yeast strains (*S. cerevisiae*, *C. albicans*). Thiosemicarbazone derivatives (**57a** and **57b**) were refluxed with appropriate α-halo carbonyl compounds such as chloroacetone and ethyl 2-bromopropanoate using anhydrous sodium acetate in ethanol to produce corresponding thiazolidine analogs **58** and **59** (Scheme [50](#Sch50){ref-type="fig"}). Among all compounds, **57a**, **57b**, **58** and **59b** showed similar antifungal activity as compared to reference drug, ketoconazole. Compound **59b** was found the most potent for antifungal activity.Scheme 50Synthesis of thiazolidine derivatives **57**(**a**--**b**), **58** and **59**(**a**--**b**)

Obydennov et al. \[[@CR104]\] synthesized 1,3-thiazolidin-4-one and pyrrolidine-2,3,5-trione motifs linked to (5*Z*)-\[2-(2,4,5-trioxopyrrolidin-3-ylidene)-4-oxo-1,3-thiazolidin-5-ylidene\]acetate derivatives via an exocyclic C=C bond, explained their isomeric form and also evaluated their in vitro fungicidal activity on *R. solani, A. solani, F. solani, C. coccodes* and *P. infestans* fungi, by the poisoned food technique. The reaction of thioamides and acetylene dicarboxylate in ethanol at ambient temperature gave 2-methylidene-1,3-thiazolidin-4-one derivatives, which reacted with oxalyl chloride in dry MeCN at 70 °C to produce 4-(4-oxo-1,3-thiazolidin-2-ylidene)pyrrolidine-2,3,5-trione derivatives **61**(**a**--**f**) in 57--87% yield. Here, compounds **60**(**a**--**f**) have a *Z* configuration of exocyclic bond in the C-5 position. In the C-2 position, configuration of the bond was affected by the solvent system, steric hindrance and intramolecular interaction such as hydrogen bonding. The authors also explained the pathway of isomerization of compounds **61**(**a**--**f**) as illustrated in Scheme [51](#Sch51){ref-type="fig"}. Compound **61b** was found to be most potent toward all the strains with EC50 values of 0.052--0.445 mg/mL using Consento as the standard drug.Scheme 51Synthesis of 4-(4-oxo-1,3-thiazolidin-2-ylidene)pyrrolidine-2,3,5-trione derivatives **61**(**a**--**f**)

Trotsko and coauthors \[[@CR105]\] synthesized (2,4-dioxothiazolidin-5-yl/ylidene)acetic acid derivatives using thiourea and maleic anhydride as starting materials under different reaction conditions, as illustrated in Scheme [52](#Sch52){ref-type="fig"}, and evaluated them for antibacterial activity using broth microdilution method. Cefuroxime and oxacillin were used as standard drugs. For reference strain, American Type Culture Collection (ATCC) *B. subtilis*, *M. luteus, B. cereus, S. aureus* and *S. epidermidis* for Gram-positive bacteria and *E. coli*, *K. pneumoniae*, *Proteus mirabilis* and *Pseudomonas aeruginosa* for Gram-negative bacteria were used. The researchers showed that the presence of an EWG at the phenyl ring was more potent as compared to an EDG; the geometry of the molecule did not affect the activity. Compound **64** was proved to be the most active compound with an MIC of 3.91 mg/L.Scheme 52Synthesis of 1,3-thiazolidin-4-ones **62** and **63**

Trotsko and his group \[[@CR106]\] synthesized thiazolidine-2,4-dione-based chlorophenyl thiosemicarbazone hybrids, which behaved as "hybrid pharmacophores" and were screened for antibacterial activity by broth microdilution technique using cefuroxime, ciprofloxacin and oxacillin as standard drugs. The authors combined two active moieties TZD (thiazolidine-2,4-dione) and thiosemicarbazides, which contain an N--N--C(=S)--N structural fragment, and they exhibited good potency of antibacterial activity at low nontoxic concentrations. The antibacterial activity was performed on 12 strains of Gram-positive and Gram-negative bacteria. Five derivatives (**65a**, **65b**, **66a**, **66b**, **68g**) were most potent against all used Gram-positive bacterial strains (Table [3](#Tab3){ref-type="table"}). The pathway of the reaction is outlined in Scheme [53](#Sch53){ref-type="fig"}.Table 3The activity of most potent chlorophenylthiosemicarbazones against Gram-positive bacteria determined on the basis of MIC (minimal inhibitory concentration, in mg/L and µM) and MBC (minimal bactericidal concentration, in mg/L and µM) with cytotoxic effect on human embryonic kidney cells (HEK-293) after 24 h of incubationCompound*S. aureusS. aureusB. subtilis*EC70 ±SD (mg/L) (toxicity threshold)ATCC 6538ATCC 25923ATCC 6633MICMBCMICMBCMICMBC**76a**3.913.913.9162.531.2512530.82 ±3.738.48.48.413567.5270**76b**3.91\> 10003.91\> 10007.8162.521.28 ±3.847.9\> 2010.67.9\> 2010.615.7125.7**77a**7.812507.812507.8125014.86 ±1.1216.9542.416.9542.416.9524.4**77b**7.815007.815007.8150010.94 ±1.3516.91084.816.91084.816.91084.8**79g**31.25\> 10007.81\> 10003.9162.519.01 ±3.8063.7\> 2036.915.9\> 2036.98127.3Cefuroxime0.98--0.49--15.63--2.31.236.8Scheme 53Synthesis of thiazolidine derivatives with highly active compounds

Xianga and colleagues \[[@CR107]\] investigated a novel synthesis of thiazolidin-2-cyanamide derivatives, and their antimicrobial activity was determined against the T3SS of *Xanthomonas oryzae* on rice. The title compounds were developed in multistep synthesis, i.e. firstly Meerwein arylation took place in substituted aniline and formed an intermediate, 5-substituted phenyl-2-furancarboxylic acid, which on reaction with thionyl chloride, 2-cyanoiminoradical-1,3-thiazolidine and K~2~CO~3~ in acetonitrile solution furnished the desired compounds in good yields (Scheme [54](#Sch54){ref-type="fig"}). The authors concluded that the new compounds reduced the symptoms of disease, displayed antivirulence effects and did not affect bacterial growth.Scheme 54Synthesis of (thiazolidin-2-ylidene) cyanamide derivatives **69**(**a**--**n**)

Abdel-Galil et al. \[[@CR108]\] synthesized thiazolidinone derivatives bearing a phenyl benzoate nucleus. The derivatives were screened for in vitro antibacterial activity against two types of bacterial strains, Gram-positive bacteria, *E. coli* and Gram-negative bacteria, *S. aureus*, and was compared with a standard chemotherapeutic drug (ampicillin) using disc diffusion method (Scheme [55](#Sch55){ref-type="fig"}). Knoevenagel condensation of thiazolidin-5-one derivatives with 4-formylphenyl benzoate in the presence of piperidine afforded arylidine products **70**(**a**--**c**). Compounds **70**(**a**--**c**) showed good to moderate activity against reference strains.Scheme 55Synthesis of thiazolidin-5-one derivatives **70**(**a**--**c**)

Barakat et al. \[[@CR109]\] described a scheme for the preparation of new derivatives of pyrrolidine/thioxothiazolidin-4-ones containing spiro-oxindole. The condensation reaction between isatin and [l]{.smallcaps}-proline generated azomethine ylide in situ, which underwent 1,3-dipolar cycloaddition with 5-arylidene-2-thioxothiazolidin-4-one (**71a** and **71b**) (prepared by a previously reported method by Knoevenagel condensation) to afford spiro-oxindole/pyrrolidine/thioxothiazolidin-4-one derivatives (**72a**, **72b**) in excellent yields (Scheme [56](#Sch56){ref-type="fig"}). These compounds were tested against two Gram-positive bacteria, *S. pneumonia* and *B. subtilis* and two Gram-negative bacteria, *P. aeruginosa* and *E. coli*, and they showed significant antibacterial properties. The antifungal activity of compounds was elucidated against *A. fumigates, S. racemosum, G. candidum* and *C. albicans* with the diffusion and serial dilution method. Fluconazole and amphotericin B were used as standard drugs. The structure of compounds **72a** and **72b** were determined with X-ray single-crystal diffraction, Hirshfeld surface analysis and DFT studies at the B3LYP/6-311G (d,p) level of theory. The 3D structures of both compounds were different, due to presence of diverse substituents at the phenyl ring and co-crystallization with solvent molecules. Compound **72a** docked with hydrophobic--hydrophobic interaction, but compound **72b** docked with both hydrophobic--hydrophobic and H-bonding interactions. Aminoglycoside phosphotransferase and lanosterol 14 α-demethylase were selected as target proteins for antibacterial and antifungal activity, respectively. Both compounds exhibited more antimicrobial activity against standard drugs. Compound **72b** gave better activity than **72a** against *B. subtilis, S. pneumonia* and *E. coli* and also showed high potency against antifungal treatment. The molecular docking study revealed that substitution on phenyl rings plays an important role in the geometry of compounds, which controls its behavior and mode of interaction. The study established that hybrid compounds **72a** and **72b** showed good results against skin infection and wound infection.Scheme 56Synthesis of compounds **71** and **72**

(*Z*)-5-Benzylidene-3-(5-heptadecyl-1,3,4-thiadiazol-2-yl) imino thiazolidin-4-one derivatives were prepared by Abdelmajeid et al. \[[@CR110]\] and were further evaluated for their antimicrobial activity against *E. coli* (Gram-negative bacterial strain), *S. aureus* (Gram-positive bacterial strain) and *A. flavus* and *C. albicans* (two fungal species) by using modified Kirby--Bauer disc diffusion technique and Mueller--Hinton agar method. Equimolar quantities of stearic acid and thiosemicarbazide in the presence of POCl~3~ produced 5-heptadecyl-1,3,4-thiadiazole-2-amine, which on chlorination with chloroacetylchloride formed 2-chloro-*N*-(5-heptadecyl-1,3,5 thiadiazole-2-yl) acetamide, which further reacted with KSCN to give 3-(5-heptadecyl-1,3,4-thiadiazol-2-yl)-2 imino thiazolidin-4-one (**73**), and **73** further combined with benzaldehyde to produce (*Z*)-5-benzylidene-3-(5-heptadecyl-1,3,4 thiadiazol-2-yl) imino thiazolidin-4-one (**74**) (Scheme [57](#Sch57){ref-type="fig"}). Compound **74** was more potent for antimicrobial activity as compared to compound (**73**). For positive control of antibacterial and antifungal activity, ampicillin and amphotericin B were used as standard drugs, respectively. Both products are safe for the environment and humans and are widely used in beauty products, fabric and dye industries as an emulsifier and wetting agent.Scheme 57Synthesis of compounds **73** and **74**

A class of novel analogs, thiazolidinediones (TZD), were prepared by Trotsko and coworkers \[[@CR111]\], and the compounds were scrutinized for in vitro antiproliferative and antibacterial activity. The synthesis of target compounds by 2-(2,4-dioxothiazolidin-5-yl/-ylidene)acetic chloride and salicylaldehyde through an efficient synthetic route is illustrated in Scheme [58](#Sch58){ref-type="fig"}. They were screened for antiproliferative activity by using normal human skin fibroblasts (BJ) and tumor cell lines, namely A549, HepG2 and MCF-7, were assessed by colorimetric MTT assay, and the antibacterial activity was determined in vitro against three Gram-positive and Gram-negative bacteria by broth microdilution. Compounds **75**(**a**, **e**, **f**, **g**, **i**, **j**) and **76**(**a**, **b**) showed antiproliferative activity against tumor cell lines. In the MCF-7 cells, the IC50 value of compound **18** was 1.59 mg/mL, which was 13 times lower then irinotecan (reference drug) and the safety index (SI) value was threefold higher than the reference strain. Compounds **75f**, **75g** and **76b** showed high potency against Gram-positive bacteria, and compound **75g** seemed to be a promising agent for anticancer treatment.Scheme 58Synthesis of 2-(2,4-dioxothiazolidin-5-yl/ylidene)acetic acid derivatives **75** and **76**

Pânzariu and coworkers \[[@CR112]\] demonstrated the synthesis of thiazolidine-4-one derivatives bearing a nitro-[l]{.smallcaps}-arginine methyl ester (NO~2~-Arg-OMe) and screened them for their antioxidant and antimicrobial activity. Novel arginine-linked thiazolidinone derivatives **77**(**a**--**j**) were synthesized in two steps; initially, one-pot condensation and cyclization reaction took place between ethyl 3-aminopropionate hydrochloride, aromatic aldehydes and TGA to form thiazolidine derivatives, which further reacted with *N*ω-nitro-[l]{.smallcaps}-arginine methyl ester hydrochloride in the presence of HOBt and EDC.HCl to furnish final products **77**(**a**--**j**) (Scheme [59](#Sch59){ref-type="fig"}). The in vitro antioxidant activity was evaluated by ferric/phosphomolybdenum reducing antioxidant power assays and DPPH/ABTS scavenging assays. For investigation of antibacterial activity, two Gram-positive (*S. aureus*, *S. lutea*) and Gram-negative (*E. coli*, *P. aeruginosa*) bacterial strains were used, and for antifungal activity, *Candida* spp. (*C. glabrata*, *C. albicans*, *C. parapsilosis*) were used. Among all compounds, **77g** and **77h** displayed high free radical scavenging ability for DPPH and ABTS radicals, whereas **77j** and **77e** exhibited the highest activity for ABTS scavenging and ferric and phosphomolybdenum reducing antioxidant power, respectively. Significant antimicrobial activity was shown by **77j** which was found most potent against *P. aeruginosa, S. aureus* and *S. lutea* strains. These properties were stimulated in the presence of bromo and nitro groups at the phenyl ring of thiazolidinone.Scheme 59Synthesis of thiazolidine-4-one derivatives **77**(**a**--**j**)

Khan et al. \[[@CR113]\] prepared a range of biphenyl tetrazole-thiazolidinedione derivatives and checked them as PDF enzyme inhibitors and for in vitro antibacterial activity. The preparation of biphenyl tetrazole-thiazolidinediones **78**(**a**--**j**) was carried out via condensation of biphenyl trityltetrazole-thiazolidinediones and THF using sodium hydroxide (Scheme [60](#Sch60){ref-type="fig"}). The antibacterial activity was screened against bacterial strains *E. coli* and *B. subtilis* using a twofold serial dilution method, and dimethyl sulfoxide was used for solvent control. PDF enzyme was taken out from *E. coli* (NCIM-2931). All derivatives **78**(**a**--**j**) showed good to high activity against *E. coli* PDF-Ni enzyme and exhibited good binding properties. Among all synthesized compounds, **78b**, **78c** and **78h** were the most potent with IC50 values of 16.25 mM, 18.00 mM and 17.25 mM, respectively. Compounds **78b**, **78c** and **78h** also showed antibacterial activity with an MIC range of 8.00--26.00 mg/mL, compared with standard ciprofloxacin. The SAR studies concluded that all reactants, thiazolidinedione (head group), acidic group (tetrazole) and the biaryl group played an important role in the inhibitory process, and the activity was also affected by substitution on the head group.Scheme 60Synthesis of biphenyl tetrazole-thiazolidineones **78**(**a**--**j**)

Gilani and coauthors \[[@CR114]\] synthesized a series of unique thiazolidinones from *N*-(6-chlorobenzo\[d\]thiazol-2-yl)hydrazine carboxamide derivatives and evaluated them for in vitro antimicrobial activity against four bacterial strains, namely, *S. aureus* (Gram-positive bacteria) or *E. coli, P. aeruginosa, K. pneumoniae* (Gram-negative bacteria) and five fungal species, namely, *C. albicans*, *A. niger*, *A. flavus*, *M. purpureus* and *P. citrinum*, via the serial plate dilution method. The compounds displayed good antimicrobial activity at 12.5--200 µg/mL in DMSO. The products were obtained from the reaction of 2-amino-6-chloro-benzothiazole and sodium cyanate which further reacted with hydrazine hydrate solution in alcohol followed by ring closure between carboxamide and aromatic aldehydes. The authors reported that the most active compounds against all bacterial strains had methyl 2,4-dichloro and 4-nitro at the phenyl ring attached to the thiazolidinones ring, and on substituting the above groups with a chloro and acetyl group, their activity was decreased. When these groups were replaced by dichloro, methyl and phenoxy substituents, they showed high potency against all tested fungal strains. Here, the Gram-positive strain showed less activity as compared to Gram-negative strain (Scheme [61](#Sch61){ref-type="fig"}).Scheme 61Synthesis of benzothiazole incorporated thiazolidin-4-one **79**

Nastasa et al. \[[@CR115]\] designed a range of new 5-(chromene-3-yl)methylene-2,4-thiazolidinone derivatives and tested them for antimicrobial activity against two Gram-positive bacteria (*L. monocytogenes*, *S. aureus*), two Gram-negative bacteria (*E. coli*, *S. typhimurium*) and one fungus strain (*C. albicans*) with the agar diffusion method. Gentamicin and fluconazole were used as reference for antibacterial and antifungal activity, respectively. The Knoevenagel condensation reaction of 6,8-dichloro-4-oxo-4*H*-chromene-3-carbaldehyde, 2,4-thiazolidinedione and anhydrous sodium acetate in acetic acid, when treated with α-bromoalkylarylketones, dimethylformamide (DMF) and anhydrous potassium hydroxide produced N-substituted 5-(chromene-3-yl) methylene-2,4-thiazolidinediones (Scheme [62](#Sch62){ref-type="fig"}). All compounds showed low to high growth inhibitory effect against the tested strains, in which compound **80g** was found most potent at all used concentrations, while compound **80f** gave better effect, and compounds **80a** and **80e** exhibited similar activity as the standard drug gentamicin.Scheme 62Synthesis of N-substituted 5-(chromene-3-yl) methylene-2,4-thiazolidinediones **80a**--**g**

Novel N-substituted-1,3-thiazolidinone derivatives were synthesized by De Monte and coworkers \[[@CR116]\], and their in vitro antifungal activity was determined against various phytopathogenic fungi, 22 *Candida* spp. (*C. tropicalis, C. albicans, C. krusei, C. glabrata, C. parapsilosis and C. sake*), and clotrimazole, ketoconazole, miconazole, fluconazole, tioconazole and amphotericin B were used as standard drugs. The thiazolidinones were designed via a contained N1 hydrogen moiety substituted with aromatic, heteroaromatic, cyclic and bicyclic structure, and on this basis it was classified into three series. Thiosemicarbazides were condensed with various carbonyl compounds using acetic acid and formed a thiosemicarbazone intermediate, which cyclized with ethyl bromoacetate in methanol and sodium acetate to form the thiazolidinone derivatives and further reacted with 4-nitrobenzyl bromide and (chloromethyl)naphthalene and *N*-(chloromethyl)phthalimide via condensation to afford the desired products **81** (**A1**--**A26**, **B1**--**B26** and **C1**--**C26**) (Scheme [63](#Sch63){ref-type="fig"}). The SAR study showed that the presence of aliphatic and aromatic (both homo and hetero) moieties affected the inhibition activity of the compounds. The final compounds did not show satisfactory inhibition for bacterial activity, but compounds **81**(**A6**, **A7**, **A10**, **B6**, **C1** and **C6**) exhibited high antifungal activity against *Candida* spp. on Hep2 cells (human laryngeal epidermoid carcinoma). The molecular docking study explained the mechanism of the desired compounds and revealed that these compounds mainly showed Van der Waals interactions with the hydrophobic binding pocket of active cells similar to the reference drug lanosterol.Scheme 63Synthesis of the N-substituted-1,3-thiazolidinone derivatives **81**

Pansare and coworkers \[[@CR117]\] introduced a one-pot three-component synthesis of 3-(4-chloro-2-hydroxyphenyl)-2-(substituted) thiazolidin-4-one using 2-amino-5-chlorophenol with different aldehydes in *N*,*N*-dimethylformamide (DMF) and glacial AcOH as a catalyst. The synthesis was carried out by both conventional and microwave heating. The compounds were further screened for antimicrobial activity (Scheme [64](#Sch64){ref-type="fig"}), and microwave-assisted synthesis afforded a high yield of the products. According to the mechanism, initially 2-amino-5-chlorophenol and benzaldehyde reacted to give imine intermediate. The imine reacted with mercaptoacetic acid and underwent intramolecular cyclization to form thiazolidinones (Scheme [65](#Sch65){ref-type="fig"}). All compounds were studied for in vitro antimicrobial activity against two Gram-positive bacteria (*B. subtilis* and *S. aureus*), two Gram-negative bacteria (*E. coli* and *S. typhimurium*) and four fungal strains (*C. albicans*, *A. flavus, A. niger* and *C. neoformans*) using a serial macrodilution method. Ciprofloxacin and ampicillin were used as reference antibacterial drugs, and fluconazole and miconazole were used as reference antifungal drugs. Among all the tested derivatives, **82f**, **82g**, **82l** and **82m** exhibited broad-spectrum activity, i.e. growth inhibitor against reference drug excluding fungus *A. niger*. Compounds **82g** and **82m** were more potent than the reference antifungal drug. All compounds also showed cytotoxicity on two cell lines, HeLa and MCF-7, using sulforhodamine B (SRB) assay. The SAR study revealed that structural variation and molecular strain affected the activity of the products. The activity of the compounds was controlled by substituents, i.e. an EDG on the phenyl ring enhanced the activity, whereas an EWG decreased activity. The remarkable features of this protocol were high yields with shorter reaction time, a unique, rapid and convenient synthesis, and all the compounds were non-cytotoxic.Scheme 64Synthesis of 3-(4-chloro-2-hydroxyphenyl)-2-substituted thiazolidin-4-ones **82**(**a**--**n**)Scheme 65Possible mechanism for the synthesis of 3-(4-chloro-2-hydroxyphenyl)-2-substituted thiazolidin-4-one **82**.Modified from Ref. \[[@CR117]\]

A series of new 4-thiazolidinones linked with a pyrone moiety were synthesized and screened for in vitro antimicrobial activity by Nechak et al. \[[@CR118]\]. All compounds were screened against five microorganisms, *Escherichia coli*, *Pseudomonas aeruginosa*, *Staphylococcus aureus* (ATCC 43300), *Staphylococcus aureus* (ATCC 25923) and *Candida albicans*. The 4-thiazolidinones **83**(**a**--**d**) were synthesized from thiosemicarbazones and ethyl 2-bromopropionate by refluxing in acetonitrile in high yields. Thiosemicarbazones and appropriate maleimide were refluxed with acetonitrile to produce thiazolidinones **83**(**a**--**h**). The mechanism showed that in the synthesis of **83**(**a**--**d**), thiosemicarbazones attacked bromoester, which underwent intramolecular cyclization (Scheme [66](#Sch66){ref-type="fig"}), while in the synthesis of **84**(**a**--**h**), thiosemicarbazone attacked the double bond of maleimide, followed by ring opening and nucleophilic attack on the nitrogen atom (Scheme [67](#Sch67){ref-type="fig"}). Among all the compounds, **83**(**a**--**d**) and **84a**--**e** (except **84d**) showed high antibacterial activity against *Pseudomonas aeruginosa*. Compound **83d** exhibited antifungal activity against *Candida albicans.* Compounds **83c** and **84**(**a**--**h**) (except **84f**) exhibited significant antibacterial activity against *S. aureus* (ATCC43300), and compounds **83a**--**d** (except **83b**) displayed the highest activity against *S. aureus* (ATCC 25923). The SAR study revealed that substitution of the R group from --CH~3~, C~2~H~5~ and H on compounds **83c** and **84e**, respectively, gave a broad spectrum of active drugs against *S. aureus* (Gram-positive bacteria) and *P. aeruginosa* (Gram-negative bacteria). In the inhibitory process, these compounds avert some intracellular and extracellular enzyme functions and microbial metabolism like DNA, RNA and protein synthesis of microorganisms.Scheme 66Proposed mechanism for the synthesis of pyrone-linked 4-thiazolidinones compounds **83**(**a**--**d**)Scheme 67Possible mechanism for the synthesis of 4-thiazolidinones **84**(**a**--**h**)

Kunzler and colleagues \[[@CR119]\] proposed a novel one-pot, two-step synthesis of 2-aryl-3-((piperidin-1-yl)ethyl)thiazolidinones **85**(**a**--**p**) from amine and arene aldehydes under refluxing toluene, and evaluated their antifungal and cytotoxic properties (Scheme [68](#Sch68){ref-type="fig"}). The in vitro antifungal activity was evaluated against *Candida albicans, Candida guilliermondii, Candida parapsilosis, Cryptococcus laurentii, Rhodotorula* sp., *Geotrichum* sp. and *Trichosporon asahii* using fluconazole as reference drug, and the cytotoxic properties were evaluated by Vero cells. The MIC and MFC values were found to be same for all synthesized compounds. The results showed that compounds **85h** and **85i** were 1.6 times more potent than fluconazole, whereas compounds **85b**, **85e**, **85g** and **85k** showed the same activity toward *Rhodotorula* spp., and all compounds, especially **85g,** were found less toxic in cytotoxicity assay. These compounds worked best in growth inhibition against *Rhodotorula* sp. yeast. The SAR study explained that the change of electronic substituents did not directly affect growth inhibition against tested phytopathogens. Developments in recent decades in the medicinal field have generated serious problems in which pathogenic bacteria continuously develop resistance to the currently used antibacterial drugs. Discovery of agents which will block pathogenic mechanisms rather than killing the infecting microbe will help overcome bacterial resistance and will aid in the development of effective treatments.Scheme 68Synthesis of 2-aryl-3-((piperidin-1-yl)ethyl)thiazolidinones **85**(**a**--**p**)

Anticancer Activity {#Sec18}
-------------------

A series of novel thiazolidinones with a 3-hydroxy-2-naphthoic motif was synthesized and tested for in vitro cytotoxicity against both HepG2 and human renal cell adenocarcinoma (769-P). The in vivo impact of the compounds on the CNS of mice was studied by Popiołeka and coauthors \[[@CR120]\]. 1,3-Thiazolidin-4-one derivatives (**86a**--**c**) were prepared via reaction of 3-hydroxy-2-naphthoic acid hydrazide with aldehydes followed by cyclization with thioglycolic acid in dioxane (Scheme [69](#Sch69){ref-type="fig"}). For reference cell lines, rat cardiac myoblasts (H9c2) and GMK were used. Compound **86c** was most potent and selective against 769-P cell lines at the IC25 concentration. The in vivo study revealed that compounds **86a**--**c** were nontoxic against the CNS of Swiss mice, showing the highest biological activity, and compound **86c** showed significant anodyne activity due to blocking of the cell cycle at the G2/M phase and stimulation of apoptosis. The authors assumed that the study of compounds (**86a**--**c**) as an anticancer drug could be linked with the cyclooxygenase-2 (COX-2) enzyme, which is associated with apoptosis, angiogenesis and metastasis effects in reference cell lines. These results confirmed significant antitumor activity of compounds (**86a**--**c**).Scheme 69Synthesis of 1,3-thiazolidin-4-one derivatives **86a**--**c**

Yakaiah and coworkers \[[@CR121]\] described a proficient one-pot multicomponent synthesis of pyrazolo-oxothiazolidine derivatives **87**(**a**--**j**) and evaluated their antiproliferative activity against A549 cell lines. Pyrazolo-oxothiazolidine derivatives were obtained in high yields (91%) from 1-(benzofuran-2-yl)-3-(substituted)-arylprop-2-en-1-ones, dialkyl acetylenedicarboxylates and thiosemicarbazide reaction at different reaction conditions and catalyst and 20 mol% of NaOH and ethanol at 80 °C (Scheme [70](#Sch70){ref-type="fig"}). For the study of antiproliferative activity of pyrazolo-oxothiazolidine derivatives, the catalytic site of receptors EGFR 14 and VEGFR2 were used, and sorafenib (IC50, 3.779 μg/mL) was used as a standard drug. The results of in vitro inhibition showed that the IC50 value of compounds **87a** (0.930 μg/mL), **87e** (1.207 μg/mL), **87f** (0.808 μg/mL), **87g** (1.078 μg/mL), **87h** (0.967 μg/mL) and **87j** (2.445 μg/mL) displayed good potency (Table [4](#Tab4){ref-type="table"}).Scheme 70Synthesis of pyrazolo-oxothiazolidine derivatives **87**(**a**--**j**)Table 4Antiproliferative activity of pyrazolo-oxothiazolidine derivatives **87a**--**j** on A549 (lung cancer) cell lineS. no.Name of compoundIC50 on A549 cell line (μg/mL)1**87a**0.9302**87e**1.2073**87f**0.8084**87g**1.0785**87h**0.9676**87j**2.4457Sorafenib3.779

Rodrigues and his group \[[@CR122]\] synthesized benzylidene-2,4-thiazolidinedione derivatives **88**(**a**--**d**) which were found to display selective cytotoxic and genotoxic activity and were screened on the NCI-H292 (human lung carcinoma), MCF-7 (breast adenocarcinoma), HEp-2 (cervix carcinoma), K562 (leukemia) and HT29 (colon adenocarcinoma) cell lines using MTT assay and non-tumor cells (human peripheral blood mononuclear cells, PBMC) using the alamarBlue assay. The aldehydes reacted with thiourea and monochloroacetic acid in an aqueous medium to produce thiazolidine-2,4-dione derivatives **88**(**a**--**d**) (Scheme [71](#Sch71){ref-type="fig"}). The highest genotoxicity and cytotoxicity was found for compound 5-(2-bromo-5-methoxybenzylidene)-thiazolidine-2,4-dione (**88d**) with the lowest IC50 value of 1.26 μg/mL for NCI-H292 which did not affect normal cells.Scheme 71Synthesis of thiazolidine derivatives **88a**--**d**

Synthesis, cytotoxicity and anticancer activity of pyridine-thiazolidinones were reported by Ansari et al. \[[@CR123]\]. To obtain unique human CAIX inhibitors, the synthesis was carried out with the mixture of 3-(furan-2-ylmethyl)-2-(phenylimino)-1,3-thiazolidin-4-one, aldehydes and hexahydropyridine using ethanol (Scheme [72](#Sch72){ref-type="fig"}). The cell cytotoxicity was identified by standard MTT assay and CAIX (PDB ID: 3IAI) was used for molecular docking study. The derivatives of **89** showed low to moderate inhibition against CAIX. Compounds **89** (**c**, **d**, **f**, **g**, **j**, **m**, **n** and **q**) (IC50 values = 50.92 μM, 57.31 μM, 40.41 μM, 40.18 μM, 63.11 μM, 60.92 μM, 38.40 μM and 43.52 μM, respectively) containing alkoxy and chloro groups displayed low inhibitory activity, and compounds 89 (**l**, **o**, **r**, **s**) (IC50 values = 20.92 μM, 16.68 μM, 6.64 μM and 10.04 μM, respectively) having a disubstituted methoxy group or heterocyclic substitution showed good inhibitory effect. Compounds 89**e**, **h** (1.61 μM), **k** (1.84 μM), and **r** (6.64 μM) with a nitro or hydroxyl group exhibited outstanding inhibitory activity. It was concluded that inhibition of CAIX not only depends on substituents but also on the molecular skeleton. HEK cell lines were used as reference for cytotoxicity. All compounds gave satisfactory activity for cancer against MCF-7 and HepG2 cell lines. Compounds **89h** and **89k** showed the most promising activity for cancer treatment.Scheme 72Synthesis of pyridine-thiazolidinone derivatives **89**(**a**--**r**)

The synthesis and anticancer activity of various thiazolidine-2,4-dione derivatives were evaluated by Asati et al. \[[@CR124]\]. The thiazolidine derivatives were obtained from 4-((2,4-dioxothiazolidin-5-ylidene)methyl)benzohydrazide and aliphatic or aromatic acids in the presence of POCl~3~ (Scheme [73](#Sch73){ref-type="fig"}) and showed anticancer activity against MCF-7 with the SRB method. The H-bonding interaction of the oxygen atom at the second and fourth position of thiazolidinedione derivatives with ASP186 and LYS67, respectively, played a vital role in the activity and nature of the substituents, which was responsible for the activity. Among the tested compounds, compound **90x** demonstrated the most marked effect in the MCF-7 cell lines (GI50 value 0.004 µM) and displayed a −6.68 docking score against PIM-1 kinase. Compounds **90c** (GI50 values 0.028), **90d** (0.012), **90e** (0.097), **90f** (0.055), **90h** (0.087), **90l** (0.087), **90o** (0.031) and **90t** (0.019) showed potent activity, while compounds **90** (**g**, **i**--**k**, **m**, **q**, **r**, **s**, **u** and **v**) showed intermediate inhibition effect. When EWGs like Cl, Br and I were used, the activity increased, and the activity decreased in the presence of EDGs like 2-methyl. The SAR studies indicated that the presence of a phenyl ring was crucial for anticancer activity.Scheme 73Synthesis of thiazolidine derivatives **90**(**a**--**x**)

A range of 4-hydroxy-thiazolidine-2-thione derivatives **91a**--**91z** were synthesized and screened for antiproliferative activity by Li and coworkers \[[@CR125]\]. For the study of the 4-hydroxy-thiazolidine-2-thione moiety as a drug, it was divided into two subunits, subunit A (the phenyl group) and subunit B (the pyridin-3-ylmethyl moiety), on the basis of their structure. The modification in subunit A was carried out by the reaction of substituted sulfonyl chlorides and 4-aminoacetophenone, and they formed intermediates which further reacted with phenyltrimethylammonium tribromide, pyridin-3-ylmethenamine and carbon disulfide (Scheme [74](#Sch74){ref-type="fig"}). This compound was more potent as pyruvate kinase M2 isoform (PKM2) activators. The SARs study using fluorescent PK-LDH coupled assay showed that the electronic and steric effect of substituents at the benzene ring affected activation activity of PKM2. Compounds **91t** and **91y** (AC50 value 0.52 µM, 0.74 µM respectively) showed higher potency than other derivatives (AC50 = 2.96 µM). The EWG (**91h**--**91m**), multi-substituents (**91d** and **91e**) and large groups which showed steric hindrance (**91n**--**91p**) on the benzene ring deactivated PKM2, and when the ring was substituted with --CH~3~ and --OCH~3~ groups at the *meta* and *para* positions, the activity was decreased, whereas a methyl group at the ortho position at nanomolar concentration increased the activity. The PKM2 activity was affected when the benzene ring was replaced with different rings (**91q**, **91r**, **91z**), replacement of the N-containing bicyclic ring with other rings, and length of carbon linker between the 4-hydroxy-thiazolidine-2-thione framework and the pyridine framework due to hydrogen bonding interaction with PKM2. The previous study showed that **91w** arrested the G2/M phase of the cell cycle in HCT116 cell lines. Here, compound **91w** (IC50 values 0.46--0.81 µM) was the most active antitumor agent against HCT116, Hela, H1299 and PC3 cell lines.Scheme 74Synthesis of novel 4-hydroxy-thiazolidine-2-thione derivatives **91**(**a**--**z**)

Kulabaş et al. \[[@CR126]\] synthesized 4-thiazolidinone derivatives from thiourea and ethyl bromoacetate and screened them for anticancer and antiviral activity. Enterovirus, Yellow fever virus, Murine norovirus and Chikungunya virus strains were used for screening of antiviral potency. 4-Thiazolidinone derivatives were obtained in two different ways; firstly, cyclization of chloroacetamide with NH~4~SCN, and secondly, cyclization of thiourea and ethyl bromoacetate with sodium acetate. In this method, five tautomeric forms were obtained (Scheme [75](#Sch75){ref-type="fig"}). All synthesized compounds have EC50 value higher than 0.3 µM. The anticancer activity was evaluated against K562, MCF-7, A549, PC-3, HT-29, HeLa and SJSA1 cell lines at a dose of 10 µM. Compounds **92** and **93** showed significant inhibition effect, i.e. 32.29% inhibition in HT29 and 35.82% inhibition in HeLa cell lines, respectively. Compound **94** was identified as the most active substance (38.92% inhibition vs. HT-29 and 35.96% inhibition vs. SJSA1) and has a high survival rate of 92.01% from NIH3T3 cell lines (Table [5](#Tab5){ref-type="table"}).Scheme 75Synthesis of 1,3-thiazolidin-4-one compounds **94** and **95**Table 5Cytotoxicity and anticancer activity of some active compounds in selected cancer cell lines \[[@CR126]\]Compound% Proliferation (at 10 µM dose)NIH3T3A549HeLaHT-29MCF-7**92**78.1289.2978.7767.7191.61**93**92.0176.2680.8961.0879.60**94**98.1974.4664.1881.8197.97

Bataille and coworkers \[[@CR127]\] synthesized novel 4-thiazolidinone derivatives and evaluated their anticancer activity for cancer in blood and lymph tissue via inhibition of the PIM kinase family by differential scanning fluorimetry (DSF). The in vitro antiproliferative activity was evaluated in two cancer cell lines (MV4-11 and K562) against selected inhibitors. They used mainly two approaches; Firstly, they synthesized fused tricyclic series through hydrolysis followed by conjugate addition, which showed significant improvement in both solubility and metabolic stability. Another approach showed improvement in metabolic activity by addition of pseudothiohydantoin in place of the rhodanine head group. A compound of series **96** was formed by Knoevenagel condensation of carbonyl compounds and rhodanine using piperidine in EtOH (Scheme [76](#Sch76){ref-type="fig"}). The other derivatives were synthesized by Suzuki--Miyaura coupling, using RB(OH)~2~ and Pd(PPh~3~)~4~ in Na~2~CO~3~, which further underwent Knoevenagel condensation with rhodanine using piperidine as catalyst to obtain tricyclic compounds. The compounds were divided into 11 classes on the basis of their structure. These series possessed better selectivity for pan-PIM kinases than other kinases. All tested compounds displayed good activity, and derivative **98b** exhibited high activity against the K562 cell line, with an IC50 value of 0.75lM. Compound **97a** has a phenyl group, and displayed a 90-fold increase in activity, with an IC50 value of 6.7 ± 3.1 nM, and the in silico study revealed that their rhodanine head group showed H-bonding interaction with water which was connected with the Lys67 residue, and this interaction was found to be sandwich-like interaction between the products and the lipophilic area of the PIM binding pocket. The SAR study indicated that an electronic effect did not play a significant role in inhibition activity. Compound **98a** containing a sulfonamide group showed excellent PIM1 inhibitor activity (IC50 25 ± 4 nM) and also provided better kinetic solubility than other compounds.Scheme 76Synthesis of 4-thiazolidinone derivatives **96**, **97** and **98** and their most biologically active compounds

Sharma and coworkers \[[@CR128]\] synthesized novel benzimidazole nucleus-linked thiazolidinedione hybrids and screened them as potential cytotoxic and apoptosis-inducing agents against human cancer cell lines, prostate (PC-3 and DU-145), breast (MDA-MB-231), A549 and MCF10A using MTT assay, and 5-FU was used as the standard drug. Novel benzimidazole-thiazolidinedione hybrids were synthesized by Knoevenagel condensation in substituted thiazolidinedione and 1-alkyl-1*H*-benzo\[*d*\]imidazole-2-carbaldehydes in moderate to high yields. The pathway of the reaction is outlined in Scheme [77](#Sch77){ref-type="fig"}. All compounds have good growth inhibition against the tested cancer cell lines. Compounds **99j**, **99p** and **99r** showed good antitumor effects with IC50 ≤ 15 μM against A549 cell lines and were safe to MCF10A (Table [6](#Tab6){ref-type="table"}). The contact of compound **99p** with the A549 cell showed arrest of the G2/M phase of the cell cycle, inhibited in vitro cell migration (using wound-healing assay) via disruption of F-actin assembly and decreased F-actin extension, and apoptotic activity such as cell contraction, cell wall distortion and decreased viable cell numbers. For induction of apoptosis acridine orange-ethidium bromide (AO-EB), annexin V-FITC/propidium iodide staining, DAPI, MitoSOX and rhodamine-123 assays were used in A549 cells for compound **99p**. According to SAR studies, the substitution on the head position gave high bioactive compounds as compared to tail substitution.Scheme 77Synthesis of (*Z*)-5-\[(1-alkyl-1H-benzo\[d\]imidazole-2-yl)methylene\]-3-(2-oxoethyl)thiazolidine-2,4-dione derivatives **99**(**a**--**t**)Table 6IC50 values (µM) of the most active compounds against selected human cancer cell lines \[[@CR128]\]CompoundPC-3DU-145MDA-MB-231A549**99j**41.10 ± 3.0837.52 ± 1.4536.03 ± 1.5313.35 ± 1.26**99p**39.87 ± 3.1631.41 ± 1.5229.18 ± 0.911.46 ± 1.46**99r**\> 5031.36 ± 1.1233.82 ± 1.3715.30 ± 0.925-FU45.32 ± 2.0840.58 ± 1.8335.98 ± 1.5230.47 ± 1.09

Kumar and coworkers \[[@CR129]\] developed a simple and direct synthesis of 4-thiazolidinone derivatives in the presence of propylphosphonic anhydride (T3P)-DMSO media as a cyclodehydrating agent and evaluated their cytotoxicity both in vitro and in vivo against leukemic cell lines (Reh and Nalm6). 4-Thiazolidine derivatives **100**(**a**--**j**) were produced from primary and secondary alcohols and aryl amines using T3P-DMSO via one-pot synthesis at high yields (Scheme [78](#Sch78){ref-type="fig"}). The relative study displayed that the compounds exhibited better activity on Reh cell lines than Nalm6 cell lines. Among all tested compounds, 3-(4-bromophenyl)-2-(4-(dimethylamino) phenyl)thiazolidin-4-one (**100e**) showed potent activity against Reh cells and Nalm6 cells with IC50 values of 11.9 μM and 13.5 μM, respectively. The cell cycle analysis showed that **100e** was able to aggregate cells in cell cycle subG1 phase, and also decreased the mitochondrial membrane potential and increased cell death in tested cell lines via apoptotic cell death. The EAC tumor model in a Swiss albino mouse revealed a significant reduction in tumor cell volume and did not affect the other organs and cells.Scheme 78Synthesis of 3-(4-bromophenyl)-2-(4-(dimethylamino)phenyl)thiazolidin-4-one (**100e**)

Anh and colleagues \[[@CR130]\] synthesized a new range of hybrid thiazolidine compounds attached with the naturally occurring paeonol. The compounds exhibited selective anticancer activity against eight cancer cell lines, HepG2, acute promyeloidleukemia, KB, LU-1 (human lung cancer), LLC, SW480 (colon adenocarcinoma), hormone-dependent prostate cancer and MCF7 (breast cancer) using MTT assay. The predicted reaction mechanism for this protocol was decoded as paeonol reacting with dimethylformamide (DMF) via Vilsmeier--Haack reaction to afford 3-formyl-7-methoxychromone, which underwent Knoevenagel condensation with 2,4-thiazolidinedione using base catalyst (piperidine or sodium acetate), to give chromonylthiazolidines **101**(**a**--**i**) (Scheme [79](#Sch79){ref-type="fig"}). All semi-synthesized compounds showed low cytotoxic effect against all cell lines; however, this cytotoxic effect was highly selective. Compounds **101a** and **101b** showed highly selective cytotoxicity in this series against KB (IC50 44.1 ± 3.6 μg/mL) and MCF7 (IC50 32.8 ± 1.4 μg/mL) cell lines, respectively. The advantages of this research are the use of easily available, affordable and natural starting material paeonol and hybrid chromonylthiazolidines as selective antitumor agents.Scheme 79Synthesis of the chromonylthiazolidine derivatives **101**(**a**--**i**)

A series of novel hybrid compounds 2, 4-thiazolidinedione incorporated pyrazole were produced and introduced for anticancer activity by Kumar and coworkers \[[@CR131]\]. 3-(Substituted aryl)-1-phenyl-1*H*-pyrazolyl-2,4-thiazolidinediones **102**(**a**--**h**) were prepared by the cyclization of substituted phenyl hydrazones via Vilsmeier--Hack reaction followed by condensation with 2, 4-thiazolidinedione employing piperidine as a catalyst in glacial acetic acid (Scheme [80](#Sch80){ref-type="fig"}). The synthesized moieties were tested for their anticancer potency against three cancer cell lines, A549, MCF-7 and DU145 using MTT based cytotoxic assay and Doxil as a reference drug. Among all the hybrids, compound **102b** emerged as a highly active cytotoxic agent for all three cancer lines, A549, MCF-7, DU145 (IC50 values 4.63, 1.32 and 5.25 μg) respectively. Compounds **102c** and **102h** showed significant activity against A549 and MCF-7 with IC50 values ranging from 4.44 to 9.16 μg.Scheme 80Synthesis of 3-(substituted aryl)-1-phenyl-1H-pyrazole-2,4-thiazolidinones derivatives **102**(**a**--**h**)

The series of substituted thiazolidinediones have been prepared and their anticancer activity and cytotoxicity were evaluated in vitro by Akshaya et al. \[[@CR132]\] 5-(4-substituted)-3-{\[(4-substituted) amino\]methyl}-1,3-thiazolidine-2,4-diones were obtained from reflux of 5-arylidene thiazolidine-2,4diones, formaldehyde and aromatic amine in the presence of methanol. The reaction proceeded via two-step mechanism involving Knoevenagel condensation of thiazolidinediones with aromatic aldehydes using [l]{.smallcaps}-tyrosine as a catalyst which further underwent Mannich reaction with aromatic amines and formed Mannich bases (Scheme [81](#Sch81){ref-type="fig"}). All derivatives showed good cytotoxic effect on both PPAR-γ using wet lab synthesis and MCF-7 cell lines by MTT assay. The outcomes of SARs revealed that presence of electron withdrawing groups like bromine, chlorine, fluorine enhanced the activity of drugs. Compounds **103a** and **103b** showed high potency against MCF-7, due to electronegativity of substituents and non-bonding valence electron, whereas presence of electron releasing group decreased activity of product against MCF-7 cell lines.Scheme 81Synthesis of 5-(4-substituted)-3-{\[(4-substituted)amino\]methyl}1,3-thiazolidine-2,4-diones **103**(**a**--**e**)

Anti-inflammatory Activity {#Sec19}
--------------------------

Yeh and coworkers \[[@CR133]\] synthesized a large panel of thiazolidinedione derivatives and evaluated them for in vitro and in vivo activity against glutaminase gene transcripts such as kidney isoform (KGA), GAC, liver isoform and GAB, and also investigated them in relation to chemical structure, activity and their selectivity. The compounds were synthesized via multistep synthesis of diketone, amine and p-toluenesulfonic acid. The intermediate obtained was further reacted with POCl~3~ in DMF to obtain bromoarene which was refluxed with corresponding arylboronic acid, sodium bicarbonate and Pd(PPh~3~)~4~ as a catalyst in the mixture of ethanol/water/DME to form an adduct, which reacted with thiazolidinedione, AcOH and piperidine using toluene to produce compound **104**. Most of the compounds exhibited high inhibition against KGA and GAC and good inhibition against GAB. The synthesized compounds inhibited cell growth, glutamate production, clonogenicity and decreased the size of tumor of xenografted human pancreatic AsPC-1 carcinoma cells in mice (Scheme [82](#Sch82){ref-type="fig"}).Scheme 82Synthesis of fused thiazolidine-2,4-dione derivative **104**

Ashour and coworkers \[[@CR134]\] synthesized substituted thiazolidinones possessing pyrazolyl benzenesulfonamides and evaluated them as anti-inflammatory active drugs by applying formalin-induced paw edema bioassay, and the analgesic activity was studied from the rat tail withdrawal technique, using diclofenac sodium as a standard drug. For the preparation of 4-\[5-amino-4\[\[(2*E*)-2-\[(5*Z*)-5-substituted-4-oxo-1,3-thiazolidin-2ylidene\]hydrazinyl\]carbonyl\]-1*H*-pyrazol-1yl\]benzenesulfonamides (**105**, **106**), firstly, ethyl 5-amino-1-(4-sulfamoylphenyl)-1*H*-pyrazole-4-carboxylate and chloroacetyl chloride were refluxed in dry DMF, which cyclized with ammonium thiocyanate in ethanol to produce an adduct in high yields and purity, followed by Knoevenagel condensation with aldehydes or 3-aryl-1-phenyl-1*H*-pyrazole-4-carboxaldehydes and piperidine in dry DMF/absolute EtOH mixture (Scheme [83](#Sch83){ref-type="fig"}). All compounds showed effective anti-inflammatory and analgesic activity. Compounds **105a**, **105b** and **106a** (45--48%) displayed superior activity than the diclofenac sodium (38%), and compounds **105a** and **106a** (22--42%) exhibited high activity as compared to the reference drug (16%). All active compounds showed minimal ulcerogenic effects. According to SAR study, after 4-h intervals, the substituted ylidene derivatives (**105b**, **106b**) were more active than the unsubstituted phenyl analogs (**105a**, **106a**). The in vitro COX inhibition assay results showed that all thiazolidinones were more selective to COX-2 than COX-1, and the motif **105b** exhibited the maximum potency for both COX-1 and COX-2 (IC50 values of 4.51 µM and 1.06 µM, respectively).Scheme 83Synthesis of pyrazolylbenzenesulfonamides-linked thiazolidinones **105** and **106**

A novel series of thiazolidinyl esters were produced from benzoic acid ester and screened as potent in vitro phosphodiesterase 4 (PDE4) inhibitors, in chronic obstructive pulmonary diseases (COPD) and related inflammatory diseases by Carzaniga et al. \[[@CR135]\]. According to the mechanism, initially alcohol coupled with the appropriate thiazolidine-carboxylic acid isomers in EDC and DMAP, which further showed Boc cleavage to obtain corresponding esters, which when sulfonylated in pyridine gave final sulfonamide products. Some synthesized compounds reacted with amine in CDI and DMF to prepare appropriate amides. Compounds (***S***\*,***S***\*\*)**-107** demonstrated ideal in vitro ADME and pharmacological properties with minimum risk of side effects, and these were highly effective in asthma and pulmonary inflammation (Fig. [8](#Fig8){ref-type="fig"}).Fig. 8(***S***\*,***S***\*\*)-**107** 3,5-Dichloro-4-((*S*)-2-(3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl)-2-((*S*)-3-(3-dimethylcarbamoyl)-phenylsulfonyl)thiazolidine-2-carbonloxy)ethyl)pyridine 1-oxide as PDE4 inhibitor

Novel thiazolidinone derivatives were designed and produced, and their potency evaluated against diabetes mellitus by Maccari and colleagues \[[@CR136]\]. Different hydroxybenzaldehydes, 2-chloroacetamide and acetonitrile were refluxed in potassium carbonate to afford 2-(formylaryloxy)acetamides. The Knoevenagel condensation of 2,4-thiazolidinedione and arylaldehydes provided **108**(**a**--**d**), whereas in different conditions, **110**(**a**--**d**) were obtained. Pure 2-\[(4-oxo-2-thioxothiazolidin-5-ylidenemethyl)phenoxy\] acetamides and (5-arylidene-4-oxo-2-thioxothiazolidin-3-yl)acetic acids were obtained by the reaction of 2-thioxo-4-thiazolidinone and (4-oxo-2-thioxothiazolidin-3-yl)acetic acid, respectively, with aldehydes by refluxing in a mixture of glacial acetic acid and sodium acetate (Scheme [84](#Sch84){ref-type="fig"}). The synthesized compounds showed anti-inflammatory activity for diabetes mellitus and other diseases via inhibited aldose reductase (AR) enzyme. The in vitro inhibition study displayed that compounds **108**--**111** exhibited good activity against reference drugs sorbinil and epalrestat. Compounds (5-arylidene-2,4-dioxothiazolidin-3-yl)acetic acids **110**(**a**--**d**) and corresponding 2-thioxo isosteres **111**(**a**--**d**) proved to be the most potent for AR inhibition. The SAR study displayed that compounds **108a**, **108c**, **109a** and **109c** were more potent than their relative *para*-substituted compounds **97b**, **97d**, **98b** and **98d**, and the presence of the *m*-methoxy group or *p*-carboxymethoxy group induced inhibition of AR enzyme. Some compounds also reduced both NF-kB activation and iNOS expression. The binding interaction between final compounds and the active site of AR was investigated by molecular docking study. The enzymatic inhibition results revealed that the fundamental 2-thioxo-4-thiazolidinone ring (**109a**--**d** and **111a**--**d**) showed more significant interaction than the isosteric 2,4-thiazolidinedione ring (**108a**--**d** and **110a**--**d**).Scheme 84Synthesis of 5-arylidene-4-thiazolidinone derivatives **108**--**111**(**a**--**d**)

Antiparasitic Activity {#Sec20}
----------------------

Oderinlo and coworkers \[[@CR137]\] synthesized new thiazolidinedione derivatives possessing organometallic ferrocene and evaluated them for antiparasitic activity. Ferrocene-containing derivatives **112**(**a**--**d**) and **114** were prepared by ferrocene carboxaldehyde, thiazolidinedione derivatives or 2-(phenylimino)thiazolidin-4-ones using piperidine in ethanol, whereas derivatives **113**(**a**--**b**) were prepared by solution of (*Z*)-(5-((ferrocenyl)methylene)-2,4-dioxothiazolidin-3-yl)acetic acid and 1-methylpiperazine or phenylpiperazine with dry DMF using EDC·HCl, HOBt·H~2~O and DIPEA (Scheme [85](#Sch85){ref-type="fig"}). All compounds were screened in vitro for antitrypanosomal activity against *Trypanosoma brucei brucei* 427 trypomastigotes, antiplasmodial activity against the chloroquine-resistant Dd2 strain of *P. falciparum* malaria parasite and cytotoxicity against the HeLa cell lines. Pentamidine (PMD), CQ and EMT were used as standard drugs. By the result of growth inhibition assay, it was concluded that the synthesized compounds exhibited higher selectivity against *T. b. brucei* than *P. falciparum*, and compounds **113a** and **113b** displayed high antitrypanosomal activity with IC50 values of 1.94 μM and 3.31 μM, respectively, when compared to TZD-4 (IC50 = 7.51 μM). In case of *P. falciparum,* none of the molecules gave better potency compared to TZD-4. All tested compounds showed non-toxicity and \> 90% HeLa cell viability, which confirmed the specificity of compounds against protozoan parasites.Scheme 85Synthesis of ferrocene carboxaldehyde thiazolidine derivatives **112**--**114**

A series of quinoline--thiazolidinone hybrids containing arylidene derivatives was developed as antimalarial agents via in vitro, in vivo and in silico study by Jain and coworkers \[[@CR138]\]. For the synthesis of novel compounds, firstly, a mixture of 2-hydrazino-4-methylquinoline reacted with various aromatic aldehydes in glacial acetic acid, and refluxed with mercaptoacetic acid using anhydrous ZnCl~2~ in 1,4 dioxane to obtain respective thiazolidinones, which reacted with aryl aldehyde in glacial acetic acid and sodium acetate and produced **115a**--**e** in good yields (Scheme [86](#Sch86){ref-type="fig"}). All the effective compounds were evaluated by in vitro schizont maturation inhibition (SMI) assay against chloroquine-sensitive strain 3D7 and chloroquine-resistant strain RKL9 strain of *Plasmodium falciparum*. Compound **115g** displayed the most potent activity against both 3D7 and RKL9 strains with EC50 (3D7/RKL-9) values of 0.423/0.824 mg/mL via in vitro study and also showed the highest parasitemia inhibition (73.38%) against *P. berghei* from in vivo study. Among all compounds, **115b**, **115e**, **115g**, **115j** and **115n** displayed significant activity from in vitro study and in vivo study against *P. berghei* in Swiss albino mice. The SAR studies concluded that the presence of a *p*-chloro group in one phenyl ring along with a *p*-methyl group in another ring gave the most potent derivative **115g** among the series. For the inhibition activity, the *p*-methyl group was more potent than the *p*-methoxy group at the phenyl ring, and the size of the ring also affected the activity of compounds. The in silico study explained the possible pathway for antimalarial activity of synthesized compounds, and the docking study proved the synthesized compounds as antimalarial agents.Scheme 86Synthesis of quinoline--thiazolidinone hybrids containing arylidene derivatives **115**(**a**--**r**)

Antiviral Activity {#Sec21}
------------------

HIV-1 RT acts as a prime target for synthesis of inhibitors for HIV/AIDS treatment. The thiazolidine nucleus contains essential pharmacophoric elements like a benzene ring, a nitrogen atom, substitution at C-2 and N-3, lipophilic characters and a biophoric space of various heterocycles around the N-3 position, which is necessary for HIV inhibition. A series of allophenylnorstatine-based peptidomimetics with various P~1~, P~2~, P~3~ and P~2~′ moieties (Fig. [9](#Fig9){ref-type="fig"}) was synthesized and screened as HIV-1 protease inhibitors by Hidaka et al. \[[@CR139]\]. All compounds with P~2~ tetrahydrofuranylglycine (Thfg) exhibited significant activity against wild-type HIV-1 protease and the virus against lopinavir/ritonavir- or darunavir-resistant strains. Among all derivatives, compound **116d** (KNI-1657) displayed strong activity against the reference strain. Compound **116a** including P~2~ (2S, 3′R)-Thfg showed 96% inhibition against HIV-1 protease at 1-nM concentration. Compound **116b** showed 98% inhibition at 60 nM, and **116c** in human serum displayed the most potent inhibition among the series. The derivatives with P3 modifications including chromonylcarbonyl, benzofurancarbonyl and 7-methoxybenzofurancarbonyl were found to be highly active against HIV protease, whereas selected P~2~′ derivatives displayed inhibition activity in a 93--97% range at 1 nM.Fig. 9Ligand selections for combinational modifications and some fused thiazolidine derivatives as HIV protease inhibitors **116**(**a**--**d**)

Antidiabetic Activity {#Sec22}
---------------------

Wang and colleagues \[[@CR140]\] designed and produced a range of novel thiazolidinedione derivatives and explained their inhibitor activity on alpha glucosidase using acarbose as the standard drug. The desired compounds **117** and **118** were synthesized via the following method: Firstly, phthalimide reacted with HCHO and formed 2-(hydroxymethyl)isoindoline-1,3-dione, which on refluxing with thionyl SOCl~2~ afforded 2-(chloromethyl)isoindoline-1,3-dione. The treatment of 2-(chloromethyl)isoindoline-1,3-dione with diverse hydroxyl-substituted aromatic aldehydes using anhydrous K~2~CO~3~ in dry acetone provided an adduct, which further underwent Knoevenagel condensation with rhodanine or thiazolidine-2,4-dione using β-alanine. It was previously observed that in the final compounds, a high yield of *Z*-stereoisomer was obtained (Scheme [87](#Sch87){ref-type="fig"}). Among all the synthesized derivatives, most compounds were potent inhibitors as compared to the reference drug. Compounds **117k**, **118a**, **118b**, **118e**, **118h** and **118k** have IC50 values of 20.95 ± 0.21, 16.11 ± 0.19, 7.72 ± 0.16, 7.91 ± 0.17, 6.59 ± 0.15 and 5.44 ± 0.13 μM, respectively, which represent their high inhibition activity. Compounds **117**(**a**, **b**, **e**, **h**, **j**) and **107**(**c**, **g**, **i**, **j**) were equipotent to reference drug acarbose. The derivative **118k** with chloro and rhodanine groups at the 2- and 4-positions of the phenyl ring, respectively, exhibited the highest inhibition activity against α-glucosidase, with an IC50 value of 5.44 ± 0.13 μM. The SAR study showed that substitution of oxygen with sulfur in final compounds displayed remarkable increase in activity. It was also observed that EWGs chloro (**117k**, **118k**) and nitro (**117h**, **118h**) at the *ortho*-position of the phenyl ring increased inhibition against the reference drug than electron-donating substituents (--OCH~3~). The binding interaction between the most active compounds and the active site of α-glucosidase was confirmed by molecular docking studies. In the binding place of α-glucosidase, compounds changed in "L-shaped" conformation, showed hydrogen bond interaction and displayed CH--π interactions with the residue of Phe-157, Phe-177 and Phe-300.Scheme 87Synthesis of thiazolidine-2,4-dione derivatives **117** and **118**

Novel substituted benzylideneamino-benzylidene-thiazolidinones were prepared and further studied for their utilization on PPAR-γ, hyperglycemia and hypoglycemia for control of diabetes mellitus by Chhajed et al. \[[@CR141]\]. Thiazolidinone was reacted with 4-nitrobenzaldehyde using sodium acetate and glacial AcOH to produce (*E*)-5-(4-nitrobenzyliden)thiazolidine-2,4-diones, which on reduction by SnCl~2~, gave (*E*)-5-(4-aminobenzyl)t hiazolidine-2,4-dione, which combined with substituted aldehyde in concentrated sulfuric acid to form (*E*)-5-((*E*)-4-((*E*)-4-benzylideneamino)benzylidene)thiazolidine-2,4-diones (Scheme [88](#Sch88){ref-type="fig"}). All compounds were tested using glucose uptake assay in 3T3-L6 cell lines with rosiglitazone as a reference drug. Among all tested compounds, **119**(**a**--**h**) exhibited strong binding with the PPAR-γ binding site, and hyperglycemic control was shown by **119a**, **119b** and **119g**. The SAR study revealed that the activity of the compounds was controlled by the benzylidine moiety's substitution. The activity was increased when a molecule substituted at the *para* position in place of the *meta* position. In the glucose uptake assay, the substituted analog with a methyl group showed 1.9-fold activity, while the ethyl group showed 0.9-fold activity.Scheme 88Synthesis of substituted bezylideneamino-benzylidene-thiazolidine-2,4-diones **119**

Kumar and group \[[@CR142]\] developed a novel synthesis of 5-((3-(aryl)-1-phenyl-1*H*-pyrazol-4-yl)methylene)-2-(*p*-tolylimino)thiazolidin-4-ones **120**(**a**--**g**) and evaluated them for in vitro α-amylase inhibition. The compound **120**(**a**--**g**) were obtained in the form of a mixture of 2*E*,5*Z* (37.1--42.0%) and 2*Z*,5*Z* isomer (58.4--62.8%). *p*-Tolyl thiourea and ethyl bromoacetate were reacted to form 2-(*p*-tolylimino) thiazolidin-4-one, that was refluxed with 3-(aryl)-1-phenyl-1*H*-pyrazole-4-carbaldehyde using piperidine in ethanol to produce desired products **120**(**a**--**g**) (Scheme [89](#Sch89){ref-type="fig"}). Compound **120a** showed 90.04% inhibition, and the docking studies concluded that interaction between **120a** and human pancreatic alpha-amylase were the same as acarbose.Scheme 89Synthesis of 5-((3-(aryl)-1-phenyl-1H-pyrazol-4-yl)methylene)-2-(p-tolylimino) thiazolidin-4-ones **120**(**a**--**g**)

Patel and coworkers \[[@CR143]\] designed a large panel of 5-\[4-(substituted) benzylidine\]thiazolidine-2,4-diones and screened them for antidiabetic activity by OGTT methods using pioglitazone as reference on male Wistar rats. The compounds were synthesized via 1,3 dipolar cycloaddition using chloroacetic acid and thiourea and water, which further underwent Knoevenagel condensation with 4-Cl benzaldehyde to furnish 5-(4-chlorobenzylidene)-2,4-thiazolidinedione. Thiazolidinedione was refluxed with primary aniline using acetonitrile and K~2~CO~3~ in microwave irradiation of 200 W to produce 5-\[4-(substituted) benzylidene\]thiazolidine-2,4-diones **121**(**a**--**j**) (Scheme [90](#Sch90){ref-type="fig"}). The thiazolidinedione ring showed strong interaction with the binding site of the receptors and showed more potency for antidiabetic activity. The presence of a lipophilic group and EDG at the second and fourth position of the aromatic ring enhanced their activity. Compound **121e** displayed high antidiabetic activity, whereas **121g** and **121h** showed moderate antidiabetic activity.Scheme 90Synthesis of 5-\[4-(substituted) benzylidene\]thiazolidine-2,4-diones **121**(**a**--**j**)

Badiger et al. \[[@CR144]\] synthesized 5-{\[2-(4-fluorobenzyl)-6-arylimidazo\[2,1-*b*\] \[1,3,4\] thiadiazol-5-yl\]methylene}thiazolidine-2,4-diones and tested them in male Wistar rats for their antidiabetic activity (in vivo hypoglycemic and hypolipidemic activity). Imidazo\[2,1-*b*\] \[1,3,4\] thiadiazoles underwent Vilsmeier--Haack reaction and formed imidazo\[2,1-*b*\] \[1,3,4\] thiadiazole-5-carbaldehydes. The mechanism involved the reaction of 2-amino-1,3,4-thiadiazole and α-haloketones (phenacylbromides) using dry ethanol to give products that were neutralized with the help of aqueous sodium carbonate solution, and the respective free bases imidazo\[2,1-b\] \[1,3,4\] thiadiazoles were obtained in high yields, which further displayed Vilsmeier--Haack reaction to give imidazo\[2,1-b\] \[1,3,4\] thiadiazole-5-carbaldehydes which further underwent Knoevenagel condensation with thiazolidinone in piperidine to yield the targeted products (Scheme [91](#Sch91){ref-type="fig"}). Compounds **122c** and **122d** exhibited good hypoglycemic and hypolipidemic activity.Scheme 91Synthesis of substituted 5-{\[2-(4-fluorobenzyl)-6-arylimidazo\[2,1-b\] \[1,3,4\] thiadiazol-5-yl\]methylene}thiazolidine-2,4-diones **122**(**a**--**d**)

Mahapatra and coworkers \[[@CR145]\] reported the fragment-based synthesis of aryl/alkylsulfonyloxy-5-(3-methoxybenzylidene)thiazolidine-2,4-dione derivatives and evaluated their biological activity for inhibition of PTP1B and anti-hyperglycemic activity. Thiazolidinones were formed by condensation of thiourea and chloroacetic acid in concentrated H~2~SO~4~, and consequently, aryl/alkylsulfonate esters were obtained by o-sulfonylation of 4-hydroxy-3-methoxybenzaldehyde in basic medium followed by Knoevenagel condensation, and TZD and aryl/alkylsulfonate esters furnished the final products, aryl/alkylsulfonyloxy-5-(3-methoxybenzylidene)thiazolidine-2,4-diones **123**(**a**--**j**) (Scheme [92](#Sch92){ref-type="fig"}). The in silico study revealed that compounds **123b** and **123e** interacted with both catalyst active sites and other aryl phosphate binding sites and also concluded that H-bonding interaction was absent. The SAR study explained that the presence of phenyl/methyl sulfonate enhanced their activity as compared to other bulky substituents, and the larger arylidene motif displayed better inhibition. Compounds **123b** (IC50 value 7.31) and **123e** (IC50 value 8.73) were potent inhibitors for in vitro PTP1B activity and in vivo anti-hyperglycemic activity. Compounds **123e** and **123i** were also good PPARγ agonists, insulin sensitizers and PTP1B inhibitors, and all the newly synthesized compounds showed potent activity for diabetes.Scheme 92Synthesis of aryl/alkylsulpfonyloxy-5-(3-methoxybenzylidene)thiazolidine-2,4-diones **123**(**a**--**j**)

Alemán-González-Duhart and coworkers \[[@CR146]\] designed a new synthetic approach to synthesize thiazolidinedione (TZD) derivatives **124a** and **124b** and tested them on the healthy animals for their nontoxic usage. Compound **124b** was synthesized by 1,3-thiazolidine-2,4-dione and salicylaldehyde in solvent-free conditions at 120 °C, and **124a** was prepared by 1,3-thiazolidine-2,4-dione and 3-chloro-2-fluorobenzaldehyde in water at 145 °C (Scheme [93](#Sch93){ref-type="fig"}). The authors investigated that the existence of EW heteroatom on aromatic ring, showed better interaction due to hydrogen bonding between the TZD head and binding site of LBD of PPARγ. Both compounds showed activity similar to other reported thiazolidinediones (rosiglitazone, pioglitazone and troglitazone).Scheme 93Synthesis of 1,3-thiazolidine-2,4-dione derivatives **124**(**a**, **b**)

Antioxidant Activity {#Sec23}
--------------------

Constantin et al. \[[@CR147]\] developed a novel, selective, nontoxic synthesis of thiazolidine-4-one derivatives containing a xanthine structure and evaluated them for antioxidant and antidiabetic activity. Initially, theophylline (1,3-dimethylxanthine) reacted with sodium methoxide and furnished the salt, which combined with ethyl chloroacetate and gave theophylline ethyl acetate. The condensation of theophylline ethyl acetate with hydrazine hydrate led to corresponding hydrazide, which when refluxed with various aromatic aldehydes, theophyllineacethydrazide derivatives were obtained and further cyclized with mercaptoacetic acid to produce theophyllinyl-acetamido-thiazolidin-4-one derivatives **125**(**a**--**k**) (Scheme [94](#Sch94){ref-type="fig"}). The in vitro antioxidant activity was done using DPPH and ABTS radical scavenging assay and phosphomolybdenum reducing antioxidant power assays. Among all synthesized compounds, **125f**, **125d**, **125c** and **125k** exhibited good activity for antiradical scavenging, and **125c** and **125k** displayed potent activity in phosphomolybdenum reducing antioxidant power. The radical scavenging activity was enhanced in the presence of methyl, methoxy and halogens (fluoro, chloro) substituents at the *para* position of the phenyl ring in final compounds.Scheme 94Synthesis of theophenyllinyl-acetamido-thiazolidin-4-one derivatives **125**(**a**--**k**)

Secci et al. \[[@CR148]\] reported the design and synthesis of 36 new thiazolidinone derivatives and evaluated them as potent antioxidants; the compounds also displayed chelating properties. For in vitro antifungal activity, all synthesized compounds were screened against six topical drugs of *Candida* spp. (*C. glabrata, C. tropicalis*, *C. albicans*, *C. krusei*, *C. parapsilosis* and *C. sakè*) and reference drugs (fluconazole, clotrimazole, ketoconazole, amphotericin B, miconazole and tioconazole) using broth microdilution method. Carbonyl compounds and thiosemicarbazide reacted in ethanol and acetic acid to form thiosemicarbazone, which underwent cyclization with ethyl bromoacetate using sodium acetate in methanol to produce 1,3-thiazolidine-4-one derivatives **126G** (**1** and **2**). The resulting compounds were refluxed with 2-/3-/4-chloro and fluorobenzyl bromide and 2-/3-nitrobenzyl bromide using anhydrous acetone and potassium carbonate to prepare *N*-substituted thiazolidinone derivatives **126**(**A**--**H**). *p*-Nitrobenzyl-*N*-substituted thiazolidinone derivatives reacted with sodium dithionite in DMF in basic aqueous solution which resulted in synthesis of 4-aminobenzyl derivatives **126I** (Scheme [95](#Sch95){ref-type="fig"}). Compound **126G3** was the most active against all tested fungal species, due to the substitution of the benzyl group with -Cl at the *meta* position with an MIC value of 2 μg/mL. Compound **126B1** also had the same effect against all species, except *C. parapsilosis.* Compounds **126**(**A3**, **C3**, **D3** and **E3**) presented moderate activity (MICs = 2 μg/mL) against *C. albicans.* The synthesized compounds have the same activity as the reference when the benzyl group was substituted with the EWG. Compounds **126**(**A3**, **B1**, **C2**, **C3**, **D3**, **E3**, **E4**, **G3**, **G4**, **H2** and **I1**) displayed the highest antifungal activity against *Candida* spp. All compounds were tested for antioxidant and metal chelating assays, reducing power from CUPRAC, free radical scavenging ability by DPPH and ABTS assay and phosphomolybdenum assays. The chelating property and antioxidant activity was estimated via EDTA and Trolox. Among the synthesized compounds, most compounds showed similar antioxidant effects and cytotoxicity as the reference compounds.Scheme 95Synthesis of N-substituted thiazolidinone derivatives **126**(**A**--**I** series)

Anticonvulsant Activity {#Sec24}
-----------------------

Faizi and coworkers \[[@CR149]\] synthesized new BZD derivatives and examined the compounds for biological evaluation. The novel compounds were synthesized by reaction of hydrazide, aldehydes and thioglycolic acid using anhydrous ZnCl~2~ in dry toluene. The synthesized compounds consisted of the functional group which easily combined with benzodiazepine receptors and 4-thiazolidinone ring as a pharmacophore moiety. Here, the mechanism showed that, firstly, an aromatic nucleophilic substitution reaction occurred in 2,4-dichlorobenzoic acid with phenol to form 2,4-chloro-2-phenoxybenzoic acid, followed by esterification, and then combined with hydrazine hydrate to yield 4-chloro-2-phenoxybenzohydrazide. The products **127**(**a**--**j**) were synthesized by treatment of 4-chloro-2-phenoxy-benzoic acid hydrazide with different benzaldehydes and were further refluxed with thioglycolic acid (Scheme [96](#Sch96){ref-type="fig"}). Compound **127i** displayed significant anticonvulsant effect in PTZ test and showed good hypnotic effect, whereas compounds **127a**, **127b**, **127e**, **127f**, **127h** and **127i** revealed good activity in the MES model. Flumazenil worked to antagonize the sedative-hypnotic effect of compounds which contain benzodiazepine. However, **127i** did not display any change in the anterograde memory and also did not show neurotoxicity. Some of the tested compounds exhibited antiepileptic effects by PTZ and MES models.Scheme 96Synthesis of 4-chloro-*N*-(2-(substituted-phenyl)-4-oxothiazolidin-3-yl)-2-phenoxybenzamide (BZD) derivatives **127**(**a**--**j**)

Nikalje and coworkers \[[@CR150]\] reported the synthesis of novel N-(2-oxo-2-(4-oxo-2-substituted thiazolidin-3ylamino)ethyl)benzamide derivatives under MW conditions. The compounds **128**(**a**--**j**) were prepared by multistep synthesis. In the first step, benzoyl chloride reacted with glycine in aq. NaOH to form 2-benzamidoacetic acid, which showed esterification and gave ethyl 2-benzamido acetate. Ethyl 2-benzamido acetate and hydrazine hydrate were refluxed in ethanol to obtain (2-hydrazinyl-2-oxoethyl)benzamide, which was further refluxed with different heterocyclic and aromatic aldehydes using glacial acetic acid in ethanol to obtain Schiff bases. Compounds **128**(**a**--**j**) were prepared under MWI for 12--17 min by cyclization of the Schiff base and thioglycolic acid, using anhydrous ZnCl~2~ and DMF (Scheme [97](#Sch97){ref-type="fig"}). The synthesis of final compounds was based on a four-point pharmacophoric HBD model, electron donor moiety (D), distal aryl domain (A) and distal hydrophilic-hydrophobic aryl ring (C) for validation using computational parameters like molecular docking, pharmacokinetic properties (ADME) and log P and for anticonvulsant evaluation, maximal electroshock seizure and subcutaneous pentylenetetrazole, and chemical testing in a mouse model. The neurotoxicity was evaluated by calculating minimal motor impairment via rotarod test. Compound **128h** showed highly potent and long-acting protection against a 30-mg/kg dose at 0.5-h and 4-h intervals, whereas compound **128f** also showed high potency only at a 0.5-h interval. But compound **128d** showed potent and long-acting inhibition against 100 mg/kg at both time intervals. Compounds **128a**, **128g** and **128h** displayed shielding of 100 mg/kg at a 0.5-h time interval in sc-PTZ screening. The SAR study manifested that the presence of small electron-donating polar groups at the phenyl ring and the presence of a heterocyclic ring (-indolyl) in the place of the aromatic ring exhibited good anticonvulsant effect. The docking studies concluded that all the newly synthesized compounds acted by inhibition voltage-gated ion channels (generally sodium channels).Scheme 97Synthesis of thiazolidine-benzamide derivatives **128**(**a**--**j**)

Miscellaneous Activity {#Sec25}
----------------------

Sabbua and colleagues \[[@CR151]\] synthesized a new amino alcohol and thiazolidinedione hybrid, inspired by aegeline, and also evaluated their anti-adipogenic activity. Compounds (*Z*)-*N*-(3-(4-((2,4-dioxothiazolidin-5-ylidene)methyl) phenoxy)-2-hydroxypropyl)benzamides were produced from Knoevenagel condensation of *N*-(3-(4-formylphenoxy)-2-hydroxypropyl)benzamide with methanol and piperidine. Other thiazolidine-2,4-dione derivatives were prepared through ring-opening reaction of (*Z*)-3-benzyl-5-(4-(oxiran-2-ylmethoxy)benzylidene)thiazolidine-2,4-dione with substituted benzylamines and picolylamines, respectively, in isopropanol under different conditions. Among all the synthesized compounds, **129** was the potent inhibitor of adipocyte differentiation, which stopped adipogenesis and lipidosis in 3T3--L1 preadipocyte cells by blocking of the S-phase of the cell cycle, prevented mitotic clonal development and decreased two vital transcription factors, PPARg and C/EBPa, and correlated genes like aP2 and FAS of adipocyte differentiation. The authors concluded that the final compounds effectively worked on obesity and related metabolic disorders (Fig. [10](#Fig10){ref-type="fig"}).Fig. 10Structure of the most anti-adipogenic compound **129** \[3-benzyl-5-(4-{2-hydroxy-3-\[(pyridin-2-ylmethyl)-amino\]-propoxy}-benzylidene)-thiazolidine-2,4-dione\]

Sousa et al. \[[@CR152]\] investigated Se-phenyl-thiazolidine-4-carboselenoate (**130**) (Se-PTC) as a protective agent against oxidative and behavioral stress in a mania model induced by ouabain (OUA), which is an extremely hazardous substance, in male rats (Fig. [11](#Fig11){ref-type="fig"}). The authors concluded that Se-PTC showed anti-manic-like action and protection against hyperlocomotion and brain oxidative stress in rats, prevented increased locomotor activity, and normalized the activity of Na^+^/K^+^-ATPase, while the LiCl (lithium chloride) blocked the increased crossing induced by OUA and also managed bipolar disorder (BD).Fig. 11Chemical structure of (*R*)-Se-phenyl thiazolidine-4-carboselenoate (Se-PTC)

Rahim and coauthors \[[@CR153]\] synthesized 4-thiazolidinone analogs and investigated them for urease inhibition. The final compounds were synthesized in two steps: initially, substituted carbonyl compounds were refluxed with thiosemicarbazide and HCl in EtOH, and Schiff bases were formed, which further reacted with chloroacetic acid and CH~3~COONa using glacial AcOH, to furnish 4-thiazolidinone derivatives **131**(**a**--**t**) (Scheme [98](#Sch98){ref-type="fig"}). All synthesized molecules gave moderate to excellent inhibition, with IC50 values in the range of 1.73--69.65 as compared to standard thiourea. Among all newly synthesized compounds, **131**(**c**, **f**, **h**, **j**, **o**, **p**, **q**, **s** and **t**) showed excellent inhibition activity with IC50 values of 9.34 ± 0.02, 14.62 ± 0.03, 8.43 ± 0.01, 7.3 ± 0.04, 2.31 ± 0.002, 5.75 ± 0.003, 8.81 ± 0.005 and 1.73 ± 0.001, respectively. The pharmacological activity of compounds was affected by the steric effect, different substituents and their positions (Table [7](#Tab7){ref-type="table"}).Scheme 98Synthesis of 4-thiazolidinone derivatives **131**(**a**--**t**)Table 7Different substituents of thiazolidine analogs **131**(**a**--**t**)

Yadav et al. \[[@CR154]\] investigated an efficient, less toxic synthesis of CBTMT and MBTMT and evaluated their corrosion inhibition activity on mild steel in 15% HCl sol. using potentiodynamic polarization, weight loss measurements and EIS techniques (Fig. [12](#Fig12){ref-type="fig"}). The concentration of inhibitor and temperature affected their efficiency of reaction: with increase in concentration, efficiency increased, but increased temperature decreased their efficiency. The weight loss measurement revealed that MBTMT (97.5%) showed higher efficiency than CBTMT (95.8%) at 303 K. This inhibition process was based mainly on adsorption, with both inhibitors obeying the Langmuir adsorption isotherm, and it was concluded that their inhibition depended on the covered surface area and number of active sites, i.e. N and S atoms. The higher value of *µ* (dipole moment) and lower value of Δ*E* (energy gap) enhanced compound inhibition efficiency.Fig. 12Structure of inhibitors CBTMT (**132**) and MBTMT (**133**)

Discussion {#Sec26}
==========

Green chemistry is a fascinating area in the field of sustainable synthesis. Green solvents and catalysts play a significant role in synthetic organic chemistry. Today's chemistry researchers need to explore new avenues of synthetic methodologies and biological applications of heterocyclic scaffolds. Though various developments have occurred in the synthetic and biological study of thiazolidine and its derivatives, there is a need for further development of the chemistry to enhance discoveries in this field. During the extensive review of the literature review on thiazolidine and its derivatives, several strengths and weaknesses were noted. For example, solvents used in the process of synthesis are hazardous to the environment, and therefore solvent-free synthesis has proven to be a boon for the environment and society, as it reduces waste and energy consumption. Solvents also serve as a heat transfer medium, and thus detailed study of their thermodynamics is required. A major drawback regarding the purification procedures (column chromatography) is that they require a large amount of solvents for purification, so extensive research is needed to avoid flaws. Ionic liquids are used as green solvents due to their recyclability, low volatility and so forth, but their high cost, safety issues and lack of generalization limit their use. In the recent scenario, crucial improvements in issues such as energy efficiency, by-product generation, impurity removal procedures, release of toxic products, whole life-cycle study and following common basic procedures with some modifications are necessary in the context of cost, population, environment, energy, health and resources. For industrial-level applications, synthesis methods could fulfill parameters including atom economy, environmental factor (e-factor), ecoscale, process profile, life-cycle analysis, environmental quotient and effective mass yield. Regarding pharmacological significance, thiazolidine-containing drugs show a variety of biological activity due to interactions such as hydrogen bonding, ion--dipole interaction, hydrophobic action, π--π interaction, Van der Waal forces and bonding with various enzymes and pharmacophores.

Besides all these concerns, several drugs containing thiazolidine derivatives are banned due to their side effects, fluid retention properties and idiosyncratic hepatotoxicity, and several are associated with risk for bladder cancer, edema, liver failure and heart failure. Therefore, critical study is needed with special emphasis on SAR and the role of PPARs in molecular mechanisms and biological activity. A better understanding of the structure of ligands and receptors and their interaction needs to be achieved. Keeping all these facts in view, thiazolidine motifs will prove to be valuable candidates for designing more effective and potent drugs by reducing their side effects. This review article includes a detailed study of thiazolidine and its derivatives, and their varied synthesis and pharmaceutical applications, and will pave a better pathway for future directions and challenges.

Conclusion {#Sec27}
==========

This review article summarizes the major developments in the fabrication of the thiazolidine nucleus and its hybrids via molecular hybridization techniques that proceed through fusion of active motifs and pharmacophore units with advantages including dual action, change in selectivity profile, lower toxicity, and the design of new scaffolds in environmentally benign conditions such as microwave- and ultrasound-mediated synthesis, reusable catalysts, easy workup and solvent-free techniques with high atom economy. The application of MW-, nanoparticle- and ionic liquid-mediated synthesis in such processes has opened a new avenue for thiazolidine formation. It is likely that in the future, many more powerful and benign methodologies will emerge in this field. Furthermore, attention should be paid to modification and substitution in thiazolidine nuclei and also toward SAR and docking studies for improving the design strategies for drug targets. On a global scale, the opportunity in the field of thiazolidine is broad for synthetic and medical discovery, and this knowledge has been applied in the synthesis of multi-target hybrid drugs, which control diseases such as diabetes, cancer, multiple sclerosis and lupus. We trust that this review will serve as an update for researchers focused on the synthesis of thiazolidine derivatives and will encourage further growth in this field.
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:   Domino ring-opening cyclization
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:   Tetrabutylammonium hydrogen sulfate
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THF
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:   Aminopropyltriethoxysilane
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DAAD
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Xoo
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DFT

:   Density functional theory
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HeLa
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:   Glutaminase C
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:   Safety index
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SAR
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GMK
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CNS

:   Central nervous system

IC50

:   Half maximal inhibitory concentration

COX-2

:   Cyclooxygenase-2
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GI
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PK-LDH
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DMAP

:   4-Dimethylaminopyridine

TZD

:   Thiazolidinedione

CDI
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:   Chronic obstructive pulmonary disease
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:   *N*,*N*-diisopropylethylamine

PDE4

:   Phosphodiesterase 4

CQ

:   Chloroquine

CQR

:   Chloroquine-resistant

ADME

:   Absorption, distribution, metabolism, excretion

EMT

:   Emetine

AR

:   Aldose reductase

HIV

:   Human immunodeficiency virus

C/EBPa

:   Enhancer-binding protein alpha

PPARγ

:   Peroxisome proliferative activator receptor gamma

SMI

:   Schizont maturation inhibition

OGTT

:   Oral glucose tolerance test

PTP1B

:   Protein-tyrosine phosphatase 1B

CUPRAC

:   Cupric ion reducing method

LBD

:   Ligand-binding domain

EDTA

:   Ethylenediaminetetraacetate

HBD

:   Hydrogen-binding domain

MES

:   Maximal electroshock seizure

PMD

:   Pentamidine

OUA

:   Ouabain

BD

:   Bipolar disorder

Se-PTC

:   Se-phenyl-thiazolidine-4-carboselenoate

CBTMT

:   (*Z*)-5-(4-Chlorobenzylidene)-3-(benzo\[d\]thiazol-2-yl)-2-(4-methoxyphenyl)thiazolidine-4-one

MBTMT

:   (*Z*)-5-(4-Methoxybenzylidene)-3-(benzo\[d\]thiazol-2-yl)-2-(4-methoxyphenyl)thiazolidine-4-one

EIS

:   Electrochemical impedance spectroscopy

EAC

:   Ehrlich ascites carcinoma
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